{"meta":{"query_hash":"94f1ed7573a0","filters":{"venue":"Journal of Dermatological Treatment"},"cohort_total":88,"direct_labels_cover":0,"predictions_cover":88,"exported":88,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/94f1ed7573a0","api":"https://metacan.xera.ac/api/v1/cohort?venue=Journal+of+Dermatological+Treatment"},"results":[{"id":"W1687877434","doi":"10.3109/09546634.2015.1034081","title":"Routes of drug delivery into the nail apparatus: Implications for the efficacy of topical nail solutions in onychomycosis","year":2015,"lang":"en","type":"article","venue":"Journal of Dermatological Treatment","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mediprobe Research (Canada); University of Toronto","funders":"","keywords":"Nail (fastener); Nail plate; Nail matrix; Medicine; Antifungal; Nail disease; Antifungal drug; Dermatology; Materials science; Paronychia","score_opus":0.08163142648153489,"score_gpt":0.3448682704347608,"score_spread":0.26323684395322594,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1687877434","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9802109,0.0074712494,0.00018126945,0.011298199,0.00006644325,0.00057236344,0.00002275177,0.0000051930515,0.0001716176],"genre_scores_gemma":[0.9980106,0.00078569795,0.00093328446,0.000103487284,0.000044434342,0.000069230104,0.0000070635438,0.0000056029708,0.000040639006],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988632,0.000085664935,0.000581938,0.00010400541,0.00018653365,0.0001786418],"domain_scores_gemma":[0.9981893,0.00088007457,0.0002953486,0.00024675485,0.00023526518,0.00015327858],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014853296,0.00012727111,0.00043823477,0.00006262685,0.00008535548,0.000008932064,0.00015070211,0.000056652745,0.0000080322525],"category_scores_gemma":[0.00021147115,0.00005290592,0.00038576775,0.00016575387,0.00015168873,0.000046958565,0.00003318022,0.000087096465,0.0000024204867],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025057732,0.011744679,0.92153764,0.00006975496,0.0019908543,0.000091050795,0.004646624,0.00025424894,0.00029762866,0.0041398634,0.00475499,0.04796687],"study_design_scores_gemma":[0.01013151,0.0014760483,0.9769354,0.00012216481,0.0013224827,0.00032801903,0.0023412905,0.0001561253,0.0013465659,0.0031672372,0.0025877533,0.000085418746],"about_ca_topic_score_codex":0.00008471092,"about_ca_topic_score_gemma":0.000039705545,"teacher_disagreement_score":0.055397727,"about_ca_system_score_codex":0.00020741408,"about_ca_system_score_gemma":0.00021918074,"threshold_uncertainty_score":0.2157441},"labels":[],"label_agreement":null},{"id":"W1964158557","doi":"10.3109/09546634.2013.852297","title":"Topical antibiotic monotherapy prescribing practices in acne vulgaris","year":2013,"lang":"en","type":"editorial","venue":"Journal of Dermatological Treatment","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Memorial University of Newfoundland","keywords":"Medicine; Acne; Medical prescription; Antibiotics; Clindamycin; Specialty; Propionibacterium acnes; Dermatology; Erythromycin; Dosing; Internal medicine; Family medicine; Pharmacology","score_opus":0.04477316509080872,"score_gpt":0.35397325429949505,"score_spread":0.30920008920868636,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1964158557","genre_codex":"empirical","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6224312,0.01680906,0.00003779125,0.0067268666,0.34962857,0.0017989248,0.000030157582,0.000056239383,0.0024812],"genre_scores_gemma":[0.37631613,0.03928197,0.004038255,0.00047372017,0.5758321,0.000055761226,0.00018003728,0.00011852354,0.0037034717],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99754137,0.00021429398,0.0009028751,0.0003225552,0.00062289083,0.0003960026],"domain_scores_gemma":[0.9969855,0.0009287644,0.0013571793,0.00026852312,0.00019495105,0.00026508063],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017573693,0.0004518653,0.001623638,0.00021899912,0.00006811711,0.00007976778,0.0001532206,0.000993298,0.00014403598],"category_scores_gemma":[0.0006262603,0.00022988724,0.0004514598,0.00011614037,0.00006606184,0.00018859067,0.00003601773,0.0008363112,0.00004637578],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017281767,0.006096555,0.05087538,0.0002846378,0.0020181863,0.015169074,0.00031082903,0.00000784421,0.00019317995,0.000017304785,0.9043097,0.018989151],"study_design_scores_gemma":[0.015685223,0.009840965,0.012838874,0.0014362729,0.0014836143,0.002054598,0.00014372861,0.000070130816,0.0011687166,0.000102555736,0.9547347,0.0004406157],"about_ca_topic_score_codex":0.000108560234,"about_ca_topic_score_gemma":0.000008097185,"teacher_disagreement_score":0.24611506,"about_ca_system_score_codex":0.0004670858,"about_ca_system_score_gemma":0.0003626713,"threshold_uncertainty_score":0.937453},"labels":[],"label_agreement":null},{"id":"W1986252942","doi":"10.3109/09546634.2014.975671","title":"A retrospective chart review of the clinical efficacy of Nd:YAG 1064-nm laser for toenail onychomycosis","year":2014,"lang":"en","type":"article","venue":"Journal of Dermatological Treatment","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mediprobe Research (Canada); University of Toronto","funders":"","keywords":"Medicine; Nail (fastener); Debridement (dental); Dermatology; Dermatophyte; Retrospective cohort study; Surgery; Regimen; Terbinafine; Nail plate; Nail disease; Clinical efficacy; Laser therapy; Dentistry; Antifungal; Laser; Complication; Itraconazole","score_opus":0.05872623661093781,"score_gpt":0.3834644224662124,"score_spread":0.3247381858552746,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1986252942","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97906435,0.01167412,0.00007308992,0.0067292904,0.00026642016,0.0012808678,0.000064625936,0.00001061,0.0008366074],"genre_scores_gemma":[0.98841155,0.009542991,0.0009136657,0.00085273694,0.00012081024,0.000023150027,0.000006738843,0.0000125781335,0.000115779345],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99784106,0.00022323884,0.0011709719,0.0001853517,0.00038544735,0.00019393917],"domain_scores_gemma":[0.997546,0.00048264881,0.0010181268,0.00036029366,0.00037363128,0.00021927776],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032238147,0.00020083509,0.0013382253,0.000045204863,0.00004867852,0.000004730378,0.00014288546,0.000101187194,0.000103141494],"category_scores_gemma":[0.0010638111,0.000089676905,0.001497776,0.00014875174,0.00013524068,0.00003971793,0.000031582702,0.00012716584,0.000007085767],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002109402,0.010185501,0.95521533,0.001362841,0.0021252802,0.00009463734,0.00004057544,0.000001514306,0.000054667624,0.00047082495,0.009106222,0.019233206],"study_design_scores_gemma":[0.014934016,0.0066020903,0.95323086,0.004879389,0.0032871368,0.00044064608,0.000019783429,0.000017269878,0.0027349999,0.0005469189,0.013191236,0.00011565238],"about_ca_topic_score_codex":0.0000029661885,"about_ca_topic_score_gemma":7.5282134e-7,"teacher_disagreement_score":0.019117555,"about_ca_system_score_codex":0.00013700593,"about_ca_system_score_gemma":0.00012637845,"threshold_uncertainty_score":0.3656918},"labels":[],"label_agreement":null},{"id":"W1992810588","doi":"10.3109/09546634.2012.703308","title":"Evidence-based optimal fluconazole dosing regimen for onychomycosis treatment","year":2012,"lang":"en","type":"review","venue":"Journal of Dermatological Treatment","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mediprobe Research (Canada); University of Toronto","funders":"","keywords":"Fluconazole; Medicine; Terbinafine; Itraconazole; Dosing; Regimen; Dermatophyte; Clinical trial; Dermatology; Mycosis; Cure rate; Surgery; Internal medicine; Antifungal","score_opus":0.3038098313424347,"score_gpt":0.4265748797926199,"score_spread":0.12276504845018515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1992810588","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00084045157,0.99524325,0.00014122037,0.0004894033,0.00033501655,0.0026267748,0.00016659593,0.000040811236,0.00011649915],"genre_scores_gemma":[0.0031494524,0.98875684,0.006343574,0.000107413536,0.0005488842,0.00054224196,0.00017652809,0.0000808196,0.00029425957],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9964857,0.00025761736,0.0015957842,0.00046004672,0.00048862887,0.00071221025],"domain_scores_gemma":[0.99567324,0.0011589437,0.001527828,0.0005191266,0.0002279971,0.00089285086],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00016933345,0.0009916874,0.0044904933,0.00036271286,0.00016936958,0.00007388023,0.00019837703,0.000490124,0.0002001962],"category_scores_gemma":[0.00009946888,0.00050135964,0.004212241,0.00022307943,0.00009122559,0.00020422817,0.000029164603,0.0002057785,0.00007858745],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00089050643,0.005822756,0.001288807,0.003391925,0.0047292435,0.0015532251,0.000024658679,0.000003445648,8.228636e-7,0.000028620907,0.0003593291,0.98190665],"study_design_scores_gemma":[0.007864753,0.007629472,0.0002636666,0.01961558,0.041945517,0.0044321776,0.000019552837,0.0000125765255,0.00007899665,0.000014788276,0.9176965,0.00042642272],"about_ca_topic_score_codex":0.00000680617,"about_ca_topic_score_gemma":4.819194e-7,"teacher_disagreement_score":0.98148024,"about_ca_system_score_codex":0.002708307,"about_ca_system_score_gemma":0.001173951,"threshold_uncertainty_score":0.9997438},"labels":[],"label_agreement":null},{"id":"W1995845116","doi":"10.1080/09546630510011801","title":"Evaluation of the efficacy of topical caffeine in the treatment of psoriasis vulgaris","year":2005,"lang":"en","type":"article","venue":"Journal of Dermatological Treatment","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Caffeine; Psoriasis; Placebo; Psoriasis Area and Severity Index; Internal medicine; Gastroenterology; Dermatology; Pathology","score_opus":0.05697133314208078,"score_gpt":0.3086893164628903,"score_spread":0.2517179833208095,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1995845116","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9907665,0.0071560713,0.0000066046355,0.0009746812,0.0002317863,0.0004313184,0.00002050874,0.000002812059,0.00040967332],"genre_scores_gemma":[0.99876785,0.0009400199,0.00013992372,0.000017176664,0.000051542866,0.000022340897,0.0000067710325,0.000004533369,0.000049810642],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99747837,0.0011497173,0.0008522892,0.00012315296,0.00022272233,0.00017376305],"domain_scores_gemma":[0.99821717,0.00061363133,0.00066573865,0.00029407992,0.00019107282,0.000018294817],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004826603,0.00018803825,0.0006574699,0.000094211326,0.000053165677,0.0000030330532,0.00024352518,0.00018287779,0.00014953951],"category_scores_gemma":[0.00012344829,0.00007708158,0.000489922,0.00017566977,0.0001716845,0.000039976556,0.000015667132,0.0000728808,0.0000058770042],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018504134,0.024741517,0.29366377,0.00002457082,0.003553987,0.000050366878,0.00878342,0.0007295546,0.030254712,0.0008411967,0.00024644256,0.63526005],"study_design_scores_gemma":[0.016169686,0.003823031,0.6165259,0.00006194609,0.0026226784,0.00048099135,0.0005952201,0.00002384151,0.35604492,0.00023080615,0.0033142236,0.00010678513],"about_ca_topic_score_codex":0.000041381183,"about_ca_topic_score_gemma":0.000058951817,"teacher_disagreement_score":0.6351533,"about_ca_system_score_codex":0.00024336968,"about_ca_system_score_gemma":0.00012213683,"threshold_uncertainty_score":0.3143296},"labels":[],"label_agreement":null},{"id":"W2017932566","doi":"10.3109/09546634.2013.865009","title":"The 5-point Investigator’s Global Assessment (IGA) Scale: A modified tool for evaluating plaque psoriasis severity in clinical trials","year":2013,"lang":"en","type":"review","venue":"Journal of Dermatological Treatment","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":261,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Dalhousie University","funders":"","keywords":"Secukinumab; Medicine; Psoriasis Area and Severity Index; Psoriasis; Clinical endpoint; Clinical trial; Surrogate endpoint; Internal medicine; Dermatology; Immunology; Psoriatic arthritis","score_opus":0.3175616168721397,"score_gpt":0.490082295512084,"score_spread":0.1725206786399443,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2017932566","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011922158,0.9792568,0.00018107954,0.00074967375,0.0029289206,0.0043595624,0.0004380293,0.00003513327,0.00012864156],"genre_scores_gemma":[0.0013637005,0.99335515,0.003099809,0.00010020841,0.0002751407,0.0014433649,0.00017987506,0.000036203593,0.00014653025],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9801594,0.011866655,0.006292042,0.0006566793,0.00022223344,0.0008030013],"domain_scores_gemma":[0.98182184,0.012437032,0.0046530105,0.0005950455,0.0002804864,0.00021257707],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.009112358,0.0009797831,0.0069476073,0.00015416436,0.00041260495,0.00013921468,0.0007340197,0.0016545287,0.000083919396],"category_scores_gemma":[0.004438059,0.00045782744,0.0039499006,0.00029759848,0.000345815,0.00014959832,0.00014468575,0.00078095985,0.00007811054],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044150098,0.0012055152,0.0016177777,0.00044084192,0.0041912617,0.0001006664,0.000027644739,0.0000034808465,0.0000035565145,0.00037754784,0.0032600998,0.9883301],"study_design_scores_gemma":[0.02317476,0.005023003,0.0030358916,0.005254388,0.016792435,0.0046739397,0.0001820301,0.00004876215,0.00007918467,0.0039909505,0.93645406,0.0012905925],"about_ca_topic_score_codex":0.000017870381,"about_ca_topic_score_gemma":0.000019242778,"teacher_disagreement_score":0.9870395,"about_ca_system_score_codex":0.0013262271,"about_ca_system_score_gemma":0.0020241446,"threshold_uncertainty_score":0.99978733},"labels":[],"label_agreement":null},{"id":"W2050849983","doi":"10.3109/09546634.2011.607795","title":"A randomized study comparing the combination of nbUVB and etanercept to etanercept monotherapy in patients with psoriasis who do not exhibit an excellent response after 12 weeks of etanercept","year":2011,"lang":"en","type":"article","venue":"Journal of Dermatological Treatment","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre de Recherche Dermatologique du Québec Métropolitain; Guenther Dermatology Research Centre; Innovaderm (Canada); Mediprobe Research (Canada); Lynde Centre for Dermatology","funders":"","keywords":"Etanercept; Medicine; Psoriasis; Dermatology; Combination therapy; Ultraviolet b; Randomized controlled trial; Internal medicine; Tumor necrosis factor alpha","score_opus":0.03614645644071029,"score_gpt":0.2553173164820604,"score_spread":0.2191708600413501,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2050849983","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997654,0.00054741144,0.000038569917,0.00013498194,0.00011935699,0.0013745409,0.000016822563,0.000008994111,0.000105295985],"genre_scores_gemma":[0.9992954,0.00020173067,0.00027240976,0.000045102057,0.000007520679,0.000098561206,0.0000066541415,0.000016516322,0.000056115325],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99533683,0.0028642025,0.0010834831,0.00028206184,0.00016771347,0.00026570924],"domain_scores_gemma":[0.99806494,0.0006866736,0.0006822017,0.00032433553,0.00017050865,0.000071350565],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010216014,0.00034641993,0.0015437584,0.00028948853,0.000082772145,0.000014208935,0.00021813225,0.00018596959,0.00019804684],"category_scores_gemma":[0.00006688975,0.0001710887,0.00023699316,0.00016238258,0.0002480119,0.00012211145,0.000047466943,0.00016067369,0.000005396978],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.46347997,0.0075925826,0.49929398,0.000010220096,0.001287905,0.00008367867,0.020216629,0.00001740004,0.0010304475,0.00004049856,0.0000094353445,0.006937268],"study_design_scores_gemma":[0.18116534,0.008107583,0.80241597,0.00008117777,0.00062621955,0.00007220456,0.0017136673,0.0000045741344,0.005552492,0.000061147344,0.000025693198,0.00017390386],"about_ca_topic_score_codex":0.000062850835,"about_ca_topic_score_gemma":0.00005009397,"teacher_disagreement_score":0.303122,"about_ca_system_score_codex":0.00009400122,"about_ca_system_score_gemma":0.000040258117,"threshold_uncertainty_score":0.69767946},"labels":[],"label_agreement":null},{"id":"W2061436092","doi":"10.3109/09546634.2011.643221","title":"A fixed-dose combination of adapalene 0.1%–BPO 2.5% allows an early and sustained improvement in quality of life and patient treatment satisfaction in severe acne","year":2011,"lang":"en","type":"article","venue":"Journal of Dermatological Treatment","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"XLV Diagnostics (Canada)","funders":"Galderma","keywords":"Medicine; Acne; Adapalene; Benzoyl peroxide; Quality of life (healthcare); Patient satisfaction; Randomized controlled trial; Regimen; Acne treatment; Dermatology Life Quality Index; Combination therapy; Minimal clinically important difference; Dermatology; Internal medicine; Physical therapy; Surgery; Nursing","score_opus":0.045473564241038655,"score_gpt":0.2971984006147316,"score_spread":0.2517248363736929,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2061436092","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99812347,0.000892393,0.0000067108263,0.00023012835,0.000031630207,0.00061185507,0.000010314244,0.0000037795012,0.00008971903],"genre_scores_gemma":[0.9982353,0.0011261363,0.0005473536,0.0000405997,0.0000064500578,0.000017468496,0.000006000297,0.000006686313,0.000013997138],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998477,0.00016910711,0.00081580976,0.00016774402,0.00020022229,0.00017016004],"domain_scores_gemma":[0.99901354,0.00009343186,0.00049634994,0.00012196969,0.000092613605,0.00018209865],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013679468,0.00019790721,0.0008097922,0.00017834971,0.000025669677,0.0000056056147,0.000024429533,0.00011730206,0.000023028817],"category_scores_gemma":[0.00004124672,0.00011269352,0.0001000882,0.00009784415,0.00006626646,0.00014465554,0.000019151043,0.00007331152,2.9100906e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029365197,0.005223418,0.94256,0.00009208509,0.0002453087,0.00026763018,0.002757286,0.0000046045393,0.0022306233,0.00012993797,0.0000029596074,0.043549623],"study_design_scores_gemma":[0.015655782,0.021724558,0.95560986,0.000107174186,0.00012673251,0.00012718256,0.001534265,0.000052913594,0.004753063,0.00020998853,0.0000080710115,0.00009038717],"about_ca_topic_score_codex":0.00084374635,"about_ca_topic_score_gemma":0.00021128461,"teacher_disagreement_score":0.043459237,"about_ca_system_score_codex":0.00024150641,"about_ca_system_score_gemma":0.000079483885,"threshold_uncertainty_score":0.45955083},"labels":[],"label_agreement":null},{"id":"W2086591847","doi":"10.1080/09546630902984596","title":"Efalizumab discontinuation: A practical strategy","year":2009,"lang":"en","type":"review","venue":"Journal of Dermatological Treatment","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Efalizumab; Medicine; Discontinuation; Psoriasis; Plaque psoriasis; Dermatology; Progressive multifocal leukoencephalopathy; Monoclonal; Pharmacology; Monoclonal antibody; Immunology; Surgery; Multiple sclerosis; Antibody","score_opus":0.12147682256946304,"score_gpt":0.37707455563146003,"score_spread":0.25559773306199696,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2086591847","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00018315349,0.9970115,0.000031559386,0.00023312727,0.000598788,0.0004931505,0.000062591935,0.000032953198,0.0013532079],"genre_scores_gemma":[0.00065871584,0.997517,0.00039311821,0.000028211774,0.00016508492,0.000041886895,0.00019869763,0.00002359327,0.00097372866],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9965674,0.0010438513,0.0015030041,0.00033772035,0.0001059149,0.00044209455],"domain_scores_gemma":[0.99721766,0.000682733,0.0015818425,0.0003149916,0.00010963605,0.000093142844],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00019283469,0.000680234,0.0032809456,0.00023255535,0.00013985284,0.00005453854,0.0002656697,0.0009357973,0.00050532445],"category_scores_gemma":[0.000103676866,0.0003523555,0.0016672065,0.00019676104,0.00011606669,0.00014638156,0.00003362378,0.00044581998,0.0005951055],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001097074,0.0017092216,0.000016038117,0.0001693217,0.0023997526,0.0020321538,0.00002690604,3.2074257e-7,0.0000014735639,0.0004892037,0.0020905954,0.9909553],"study_design_scores_gemma":[0.0020826228,0.0022538216,0.000058387694,0.0014393164,0.0057040555,0.024799801,0.000031661275,9.0807994e-8,0.000040263847,0.00015089179,0.9631257,0.00031335143],"about_ca_topic_score_codex":0.0000020814773,"about_ca_topic_score_gemma":0.000001858413,"teacher_disagreement_score":0.99064195,"about_ca_system_score_codex":0.00034977542,"about_ca_system_score_gemma":0.00057489274,"threshold_uncertainty_score":0.99989283},"labels":[],"label_agreement":null},{"id":"W2103499669","doi":"10.3109/09546634.2012.713458","title":"Effect of adalimumab on sleep parameters in patients with psoriasis and obstructive sleep apnea: a randomized controlled trial","year":2012,"lang":"en","type":"article","venue":"Journal of Dermatological Treatment","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Innovaderm (Canada)","funders":"","keywords":"Medicine; Adalimumab; Psoriasis; Polysomnography; Obstructive sleep apnea; Randomized controlled trial; Placebo; Sleep apnea; Internal medicine; Psoriasis Area and Severity Index; Anesthesia; Apnea; Dermatology; Tumor necrosis factor alpha","score_opus":0.009382823303474402,"score_gpt":0.2342899557498504,"score_spread":0.224907132446376,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2103499669","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99441075,0.002364366,0.000012418489,0.00004995908,0.00067541114,0.0023318357,0.000015151746,0.000008722179,0.00013135714],"genre_scores_gemma":[0.9994385,0.00010856164,0.00016905996,0.000018349743,0.000026244985,0.0002015374,0.000013579549,0.000010780782,0.000013347543],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9962909,0.0021849584,0.00089441036,0.00017474902,0.000111555455,0.00034342252],"domain_scores_gemma":[0.9954654,0.0033891313,0.00086414866,0.00014176256,0.000069183625,0.00007036901],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006287076,0.000361272,0.0027855954,0.0002225008,0.00006217617,0.0000085577285,0.00009067371,0.00025152383,0.000032902957],"category_scores_gemma":[0.000330207,0.0001609675,0.0005435169,0.00010510757,0.00021548024,0.00011020669,0.00001809106,0.00015015906,0.000008499804],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8997007,0.0021214285,0.077632934,0.000010101347,0.003657883,0.000028729242,0.0002855479,0.000014949376,0.00003664835,0.00006214497,0.000004626077,0.01644433],"study_design_scores_gemma":[0.9556906,0.012390848,0.020973885,0.000042157073,0.002114014,0.000098021155,0.00004637386,0.0000029928212,0.008447831,0.000032230815,0.000016557015,0.00014445082],"about_ca_topic_score_codex":0.0000068497498,"about_ca_topic_score_gemma":8.90556e-7,"teacher_disagreement_score":0.05665905,"about_ca_system_score_codex":0.00011321314,"about_ca_system_score_gemma":0.00001777595,"threshold_uncertainty_score":0.6564064},"labels":[],"label_agreement":null},{"id":"W2143292648","doi":"10.1080/09546630050517658","title":"Itraconazole pulse therapy is effective in dermatophyte onychomycosis of the toenail: a double-blind placebo-controlled study","year":2000,"lang":"en","type":"article","venue":"Journal of Dermatological Treatment","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alberta Children's Hospital; Rockyview General Hospital; Centre Hospitalier de l’Université de Montréal; University of Calgary; University of British Columbia; Hôtel-Dieu de Montréal; Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Itraconazole; Medicine; Dermatophyte; Placebo; Adverse effect; Ketoconazole; Griseofulvin; Mycosis; Randomized controlled trial; Dermatology; Internal medicine; Surgery; Antifungal; Pathology","score_opus":0.034680874370046265,"score_gpt":0.3301356256944479,"score_spread":0.29545475132440163,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2143292648","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914079,0.0024143497,7.4308934e-7,0.0012711912,0.00007335571,0.0035914038,0.000011772359,0.000009729852,0.0012195964],"genre_scores_gemma":[0.99810237,0.0010000139,0.000043983942,0.00037249154,0.00004069012,0.0002474224,0.000001688287,0.000015099141,0.0001762202],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99787986,0.00028579734,0.0008676956,0.00021908373,0.00046692655,0.00028062114],"domain_scores_gemma":[0.9987317,0.00025067307,0.00039965272,0.00030915302,0.000114265735,0.00019455656],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013604847,0.00031109987,0.0012620471,0.00013756477,0.00007612483,0.000021764807,0.00015517682,0.00010573006,0.0006232545],"category_scores_gemma":[0.000020502754,0.0001393801,0.0007941316,0.00029183604,0.00006908304,0.00009841569,0.000017604896,0.0002000931,0.00002096825],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.19089675,0.02455631,0.75041693,0.00002307223,0.0030600517,0.0019704078,0.0009113419,0.000046157857,0.00012802135,0.000009278046,0.0001260038,0.027855642],"study_design_scores_gemma":[0.3674758,0.003985962,0.61996996,0.00014932013,0.00095918914,0.00093616574,0.0002808401,0.00003530975,0.0056209387,0.00012228021,0.0003332468,0.0001310145],"about_ca_topic_score_codex":0.000043866152,"about_ca_topic_score_gemma":0.000009015605,"teacher_disagreement_score":0.17657904,"about_ca_system_score_codex":0.00023365393,"about_ca_system_score_gemma":0.00012259914,"threshold_uncertainty_score":0.68241996},"labels":[],"label_agreement":null},{"id":"W2331284076","doi":"10.3109/09546634.2014.952608","title":"Open-label exploratory study of acitretin for the treatment of severe chronic hand dermatitis","year":2014,"lang":"en","type":"article","venue":"Journal of Dermatological Treatment","topic":"Contact Dermatitis and Allergies","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Innovaderm (Canada); Windsor Clinical Research","funders":"Actelion Pharmaceuticals","keywords":"Acitretin; Medicine; Psoriasis; Dermatology; Plaque psoriasis; Severity of illness; Internal medicine; Psoriasis Area and Severity Index","score_opus":0.0768447787380526,"score_gpt":0.3333239567455587,"score_spread":0.2564791780075061,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2331284076","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9920971,0.0040433137,0.0002292752,0.0018283129,0.0001333106,0.0014176745,0.000021055052,0.0000065519125,0.00022344897],"genre_scores_gemma":[0.99657434,0.002397371,0.0005884057,0.00011244427,0.00009171231,0.00011595276,0.0000046123455,0.000013371806,0.00010178143],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9983323,0.000148807,0.00090172736,0.00014235183,0.00027812936,0.00019666215],"domain_scores_gemma":[0.9979224,0.0006997286,0.00070518436,0.0003100262,0.00024626456,0.00011636683],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014092699,0.00022987914,0.0010841285,0.00007897225,0.00012586123,0.000040729756,0.00022848818,0.00007225908,0.0000735735],"category_scores_gemma":[0.00007002014,0.000107613356,0.00023024972,0.000091666305,0.00010321851,0.00012023479,0.00004153395,0.00006377379,0.0000027297262],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00539864,0.121936806,0.22803278,0.0010416077,0.015443931,0.0016830732,0.032706708,0.0005002333,0.0077896197,0.00147021,0.011279027,0.57271737],"study_design_scores_gemma":[0.21565646,0.22634412,0.2742153,0.0013630894,0.005991252,0.006066036,0.01738418,0.0021108221,0.07310393,0.00085769943,0.17608061,0.0008265034],"about_ca_topic_score_codex":0.000021914331,"about_ca_topic_score_gemma":0.00008822952,"teacher_disagreement_score":0.57189083,"about_ca_system_score_codex":0.00023081359,"about_ca_system_score_gemma":0.0001466734,"threshold_uncertainty_score":0.43883452},"labels":[],"label_agreement":null},{"id":"W2613579314","doi":"10.1080/09546634.2017.1329499","title":"What is clearance worth? Patients’ stated risk tolerance for psoriasis treatments","year":2017,"lang":"en","type":"article","venue":"Journal of Dermatological Treatment","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Eli Lilly (Canada)","funders":"Duke University; Eli Lilly and Company","keywords":"Medicine; Psoriasis; Plaque psoriasis; Regimen; Dermatology; Logistic regression; Surgery; Internal medicine","score_opus":0.03240300307459103,"score_gpt":0.2863386960471726,"score_spread":0.25393569297258156,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2613579314","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9848159,0.010850961,0.00005432096,0.00047180447,0.0027082607,0.0005627727,0.00031469585,0.000033515447,0.00018775767],"genre_scores_gemma":[0.9796036,0.018537067,0.0006946277,0.00011242488,0.000076586024,0.00008103941,0.000065273045,0.000023828754,0.000805578],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982677,0.00017788858,0.000691812,0.00030792513,0.00009122588,0.000463451],"domain_scores_gemma":[0.99787724,0.00022168344,0.0010768878,0.0004999184,0.00023499047,0.00008930376],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00011935048,0.00039933788,0.00086228934,0.00008950465,0.0007581934,0.00015479545,0.00039405123,0.00030118437,0.00013537295],"category_scores_gemma":[0.00006916061,0.00024907675,0.00058050716,0.00004939965,0.00017569854,0.0005820362,0.000035787012,0.00013442147,0.00012321753],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032630211,0.003061931,0.51436937,0.000022572458,0.0045323456,0.00013881573,0.00075121294,0.00002098778,0.00038140017,0.000047772093,0.0037937693,0.46961683],"study_design_scores_gemma":[0.034006983,0.004423287,0.84847945,0.00019446021,0.002383182,0.00028094937,0.00024045659,0.000017595155,0.0567304,0.0011164121,0.051563397,0.00056343485],"about_ca_topic_score_codex":0.000012988513,"about_ca_topic_score_gemma":0.0000069949183,"teacher_disagreement_score":0.4690534,"about_ca_system_score_codex":0.00018738088,"about_ca_system_score_gemma":0.0000506867,"threshold_uncertainty_score":0.9999961},"labels":[],"label_agreement":null},{"id":"W2625462019","doi":"10.1080/09546634.2017.1343435","title":"Defining treatment success in rosacea as ‘clear’ may provide multiple patient benefits: results of a pooled analysis","year":2017,"lang":"en","type":"article","venue":"Journal of Dermatological Treatment","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Windsor Clinical Research; Western University","funders":"Galderma","keywords":"Rosacea; Medicine; Dermatology Life Quality Index; Internal medicine; Randomized controlled trial; Quality of life (healthcare); Metronidazole; Clinical endpoint; Dermatology; Gastroenterology; Acne","score_opus":0.028051389488389117,"score_gpt":0.31710719955368644,"score_spread":0.28905581006529735,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2625462019","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99424666,0.0019693982,0.0000074858185,0.0020067235,0.00008800163,0.0005166003,0.00006687869,0.000012413656,0.0010858629],"genre_scores_gemma":[0.99765027,0.0009861772,0.0010243767,0.00008029589,0.000032751923,0.000027944823,0.000037500857,0.000014711688,0.00014594766],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99770653,0.00012689474,0.0011025238,0.000309839,0.00038564007,0.00036856928],"domain_scores_gemma":[0.99748576,0.0002865753,0.0012611535,0.0005221296,0.00015432911,0.00029003297],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015724087,0.00034764677,0.0015046177,0.00034381822,0.00020878439,0.00005887933,0.00015693535,0.00018214763,0.000032376458],"category_scores_gemma":[0.0003393321,0.00018050736,0.0007553802,0.00020345798,0.0001040345,0.00017234286,0.000054193726,0.00013162955,0.000014061918],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005170862,0.0057673077,0.9363714,0.00003276696,0.0045673074,0.0045936177,0.0007676292,0.0010666066,0.00010397996,0.00007301761,0.000057178204,0.041428357],"study_design_scores_gemma":[0.03623139,0.020625858,0.906959,0.0005419812,0.0077510816,0.000931931,0.00060488196,0.0012410461,0.022488208,0.000060926104,0.0022261527,0.0003375502],"about_ca_topic_score_codex":0.0007358783,"about_ca_topic_score_gemma":0.00016278472,"teacher_disagreement_score":0.04109081,"about_ca_system_score_codex":0.0004227076,"about_ca_system_score_gemma":0.00016349745,"threshold_uncertainty_score":0.7360876},"labels":[],"label_agreement":null},{"id":"W2760547991","doi":"10.1080/09546634.2017.1385719","title":"Optimal hidradenitis suppurativa topical treatment and wound care management: a revised algorithm","year":2017,"lang":"en","type":"article","venue":"Journal of Dermatological Treatment","topic":"Hidradenitis Suppurativa and Treatments","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; Women's College Hospital; University of Toronto","funders":"","keywords":"Hidradenitis suppurativa; Medicine; Dermatology; Wound care; Algorithm; Surgery; Pathology; Disease","score_opus":0.032124803347614174,"score_gpt":0.32221595158650507,"score_spread":0.2900911482388909,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2760547991","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96241325,0.004268291,0.00030479993,0.021765342,0.0003295572,0.0014573272,0.00007987032,0.000051977626,0.009329592],"genre_scores_gemma":[0.9776488,0.002876603,0.018094456,0.00001783259,0.00018969394,0.000046078752,0.00002816336,0.000020678995,0.0010777047],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99827814,0.00010220255,0.0006051513,0.00032485597,0.0003144566,0.00037518007],"domain_scores_gemma":[0.99845654,0.00008331457,0.00041660818,0.00045721198,0.00012868959,0.00045761425],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000069170887,0.0004085388,0.0010074435,0.00012729429,0.00049385545,0.0002036628,0.00015804697,0.00017291786,0.00019187602],"category_scores_gemma":[0.00003435539,0.00023529833,0.0003908308,0.00004687066,0.0002407378,0.00028687782,0.00006727443,0.00014989427,0.00003057915],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007876849,0.0025449416,0.13101108,0.0001346859,0.0025763307,0.4681941,0.0016645389,4.4281327e-7,0.000084768304,0.0005312435,0.00021162607,0.39225855],"study_design_scores_gemma":[0.042803403,0.017727893,0.15513872,0.00061919173,0.0039002956,0.7322226,0.0028867316,0.00011523118,0.0046324506,0.0003687596,0.038882032,0.00070265733],"about_ca_topic_score_codex":0.000017282446,"about_ca_topic_score_gemma":0.0000032650164,"teacher_disagreement_score":0.3915559,"about_ca_system_score_codex":0.00050465245,"about_ca_system_score_gemma":0.00008248392,"threshold_uncertainty_score":0.95951873},"labels":[],"label_agreement":null},{"id":"W2892779110","doi":"10.1080/09546634.2018.1530439","title":"Pharmacokinetic disposition of topical phosphodiesterase-4 inhibitor E6005 in patients with atopic dermatitis","year":2018,"lang":"en","type":"article","venue":"Journal of Dermatological Treatment","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Eisai Canada","keywords":"Medicine; Atopic dermatitis; Pharmacokinetics; Adverse effect; Incidence (geometry); Drug; Dermatology; Logistic regression; Metabolite; Internal medicine; Clinical significance; Pharmacology","score_opus":0.011355264498628602,"score_gpt":0.27060175727833735,"score_spread":0.25924649277970874,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2892779110","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997945,0.00035870782,0.000062528445,0.00078037236,0.00011642917,0.0002293718,0.0000076623855,0.000008397012,0.0004915063],"genre_scores_gemma":[0.998824,0.000047969323,0.0006527232,0.00036894743,0.000064499865,0.00000732439,0.000010027643,0.0000062658087,0.000018249513],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988539,0.00008754235,0.0005406764,0.00011116833,0.0002340127,0.0001726944],"domain_scores_gemma":[0.9992585,0.000076520395,0.00024218026,0.00011092297,0.00016931079,0.00014254339],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000313518,0.00014760626,0.0005201369,0.00010579816,0.00003385312,0.0000063818125,0.00006106146,0.000086554086,0.0001409568],"category_scores_gemma":[0.000033333432,0.00008371231,0.00012109596,0.00011546756,0.00020849971,0.000095609124,0.00001613837,0.00010018823,0.000009485239],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006749427,0.002096249,0.9926374,0.000046319994,0.00012987189,0.00078298297,0.00017045788,0.0000014450625,0.0000477894,0.000032344815,0.0004272258,0.0029529831],"study_design_scores_gemma":[0.0081823245,0.0020020406,0.9747672,0.00022275631,0.0002082102,0.00085528,0.000038013583,0.000016984475,0.012959614,0.0000838217,0.00058672606,0.00007699632],"about_ca_topic_score_codex":0.000002456711,"about_ca_topic_score_gemma":0.0000032130645,"teacher_disagreement_score":0.017870156,"about_ca_system_score_codex":0.000097691525,"about_ca_system_score_gemma":0.00005657356,"threshold_uncertainty_score":0.34136888},"labels":[],"label_agreement":null},{"id":"W2904898191","doi":"10.1080/09546634.2018.1529386","title":"The journey for US psoriasis patients prescribed a topical: a retrospective database evaluation of patient progression to oral and/or biologic treatment","year":2018,"lang":"en","type":"article","venue":"Journal of Dermatological Treatment","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"LEO Pharma; Galderma; Sun Pharma; Mylan; Regeneron Pharmaceuticals; Celgene; Valeant Pharmaceuticals International; Sanofi; Eli Lilly and Company; Pfizer; National Psoriasis Foundation","keywords":"Medicine; Psoriasis; Retrospective cohort study; Biologic Agents; Topical agents; Internal medicine; Cohort; Observational study; Surgery; Dermatology; Disease","score_opus":0.0723164090166498,"score_gpt":0.34736504590440037,"score_spread":0.27504863688775055,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2904898191","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99491876,0.0020389017,0.000051858686,0.0004809685,0.00069671887,0.0015880957,0.00015866723,0.000013420297,0.000052585423],"genre_scores_gemma":[0.9972245,0.00061243336,0.0016690248,0.00005296137,0.00005839573,0.0002708764,0.00005229053,0.000010009948,0.000049473445],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99787956,0.0006277069,0.00071234576,0.00027968257,0.00016418786,0.00033652943],"domain_scores_gemma":[0.9979261,0.00038662806,0.00060283026,0.00024870728,0.00074690557,0.00008882896],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000392741,0.00028169595,0.000616507,0.00010331857,0.0003525634,0.000024905663,0.00015037427,0.0001838927,0.00006724582],"category_scores_gemma":[0.0005522589,0.00011709021,0.00023883992,0.00013715393,0.00019833104,0.00008361571,0.000058950016,0.00006429223,0.000010508836],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014957587,0.0054256096,0.20760067,0.000015526306,0.0024705562,0.000043380765,0.0014067483,0.0000041677617,0.004509374,0.00020883756,0.0010447768,0.76231277],"study_design_scores_gemma":[0.046614446,0.13448404,0.47065532,0.00032052668,0.004648486,0.0009659691,0.0011148282,0.00007694922,0.29062065,0.0015472962,0.048285708,0.0006657564],"about_ca_topic_score_codex":0.000015728305,"about_ca_topic_score_gemma":0.00004784506,"teacher_disagreement_score":0.761647,"about_ca_system_score_codex":0.00039179748,"about_ca_system_score_gemma":0.00012786029,"threshold_uncertainty_score":0.47748},"labels":[],"label_agreement":null},{"id":"W2919298825","doi":"10.1080/09546634.2019.1577346","title":"The Decoy Effect","year":2019,"lang":"en","type":"editorial","venue":"Journal of Dermatological Treatment","topic":"Mental Health and Psychiatry","field":"Arts and Humanities","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Janssen Biotech; LEO Pharma; Almirall; Galderma; Regeneron Pharmaceuticals; Sun Pharma; Mylan; National Psoriasis Foundation; Valeant Pharmaceuticals International; AbbVie; Celgene; Novartis; Pfizer","keywords":"Medicine; Psoriasis; Dermatology; Decoy; Pharmacology; Intensive care medicine; Internal medicine","score_opus":0.018810102207196273,"score_gpt":0.29655966380858917,"score_spread":0.2777495616013929,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2919298825","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0025916342,0.009408893,5.954854e-7,0.0010168364,0.9656675,0.00032811647,0.000081820406,0.000013233427,0.020891378],"genre_scores_gemma":[0.0068728635,0.003859579,0.000022933551,0.00016268154,0.97838473,0.000023273125,0.000048189122,0.000027939646,0.010597792],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99793965,0.00028219618,0.0007346397,0.00014146684,0.0005687556,0.00033331363],"domain_scores_gemma":[0.99554783,0.0031402805,0.0007852015,0.00021652316,0.00014109696,0.00016906619],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033585017,0.00030691575,0.0007344283,0.000053728087,0.00048214803,0.00021211785,0.00032694754,0.0002975656,0.0004248688],"category_scores_gemma":[0.00011847706,0.00012075129,0.00050557114,0.000015029919,0.0001332635,0.000062310486,0.000024954032,0.00056770415,0.00035864147],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034792832,0.0001452956,0.00014369989,0.000095335374,0.00021594949,0.000104834326,0.0003300101,2.838411e-7,5.8728258e-8,0.0014323336,0.9925372,0.0046470445],"study_design_scores_gemma":[0.0012805923,0.0028566734,0.000010937105,0.000116896816,0.00016260814,0.00007576595,0.00014699236,0.0000010438652,0.0000055762102,0.0004867561,0.99473464,0.00012148462],"about_ca_topic_score_codex":0.000017041519,"about_ca_topic_score_gemma":0.00007007423,"teacher_disagreement_score":0.012717254,"about_ca_system_score_codex":0.00023003251,"about_ca_system_score_gemma":0.0002799369,"threshold_uncertainty_score":0.4924095},"labels":[],"label_agreement":null},{"id":"W2924267060","doi":"10.1080/09546634.2019.1587145","title":"Efficacy and safety of guselkumab, administered with a novel patient-controlled injector (One-Press), for moderate-to-severe psoriasis: results from the phase 3 ORION study","year":2019,"lang":"en","type":"article","venue":"Journal of Dermatological Treatment","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; University of British Columbia","funders":"Janssen Research and Development; Eli Lilly and Company","keywords":"Medicine; Psoriasis; Psoriasis Area and Severity Index; Placebo; Adverse effect; Dosing; Interim analysis; Internal medicine; Randomized controlled trial; Dermatology; Surgery","score_opus":0.04277174648646291,"score_gpt":0.2797984276950329,"score_spread":0.23702668120856996,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2924267060","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936316,0.00157072,0.000117004674,0.00042905356,0.00029847847,0.0029331986,0.0009460147,0.0000145057065,0.000059443824],"genre_scores_gemma":[0.99877936,0.00013303972,0.0006946493,0.00006767481,0.00003786736,0.00011064772,0.000077271055,0.00001555795,0.000083953455],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99790066,0.00036636667,0.0010040401,0.00033993498,0.00011223893,0.0002767505],"domain_scores_gemma":[0.99682796,0.0017530354,0.000810573,0.00034632266,0.00019046097,0.00007166861],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000208329,0.0003329859,0.0012373526,0.00007065715,0.0001549365,0.000028912911,0.00020241598,0.00017787635,0.000032543405],"category_scores_gemma":[0.00017072493,0.00015475962,0.00023213288,0.00008727632,0.00006040473,0.000085441185,0.000049435075,0.00011669016,0.000008367087],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8797246,0.023171457,0.015358744,0.000023174483,0.014467012,0.00011115555,0.008434759,0.00028084233,0.022659766,0.000087990236,0.00039934437,0.03528115],"study_design_scores_gemma":[0.82140744,0.07207971,0.04811683,0.00034928726,0.0051784553,0.00070808694,0.0035230948,0.000048594342,0.043110996,0.00006475473,0.004790442,0.0006223093],"about_ca_topic_score_codex":0.000038788105,"about_ca_topic_score_gemma":0.000022474604,"teacher_disagreement_score":0.058317166,"about_ca_system_score_codex":0.000073937015,"about_ca_system_score_gemma":0.0000868028,"threshold_uncertainty_score":0.6310914},"labels":[],"label_agreement":null},{"id":"W2924550304","doi":"10.1080/09546634.2019.1587144","title":"Real-world use of extracorporeal photopheresis for patients with cutaneous T-cell lymphoma in the United States: 2010–2015","year":2019,"lang":"en","type":"article","venue":"Journal of Dermatological Treatment","topic":"Cutaneous lymphoproliferative disorders research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Mallinckrodt Pharmaceuticals","keywords":"Medicine; Extracorporeal Photopheresis; Photopheresis; Cutaneous T-cell lymphoma; Dermatology; Lymphoma; Extracorporeal; Surgery; Mycosis fungoides; Internal medicine; Disease; Graft-versus-host disease","score_opus":0.042319942350103674,"score_gpt":0.3111525509298505,"score_spread":0.26883260857974683,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2924550304","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99707615,0.00007737882,0.000027195734,0.0007712899,0.00004106531,0.001606,0.00006537362,0.0000071851373,0.00032836918],"genre_scores_gemma":[0.9968892,0.0005138596,0.001515966,0.00022650286,0.000014870372,0.000035769954,0.000104104794,0.000022134933,0.00067759387],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979312,0.0002098495,0.0006936926,0.00019286365,0.0006351195,0.0003372978],"domain_scores_gemma":[0.99741864,0.0011334091,0.00045719967,0.00028540098,0.00055805605,0.00014726292],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013312258,0.00023963775,0.00072768587,0.00033364596,0.000041943465,0.00003015986,0.00016453714,0.000092536204,0.00009866123],"category_scores_gemma":[0.000091098715,0.000111448615,0.0002152129,0.00042670142,0.000116645046,0.00008006346,0.000019107743,0.00011907678,0.0000076999895],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010615253,0.008682769,0.9741027,0.00011901575,0.0002880558,0.0019322744,0.00057998666,0.00027649954,0.00022787585,0.0000321615,0.0022680268,0.0008753982],"study_design_scores_gemma":[0.11350081,0.055066776,0.7637903,0.0009561423,0.0012754207,0.017952796,0.0043311627,0.0066402466,0.007936665,0.0007143266,0.026871758,0.0009635865],"about_ca_topic_score_codex":0.00033623297,"about_ca_topic_score_gemma":0.0001410683,"teacher_disagreement_score":0.21031238,"about_ca_system_score_codex":0.000366473,"about_ca_system_score_gemma":0.00023936802,"threshold_uncertainty_score":0.45447424},"labels":[],"label_agreement":null},{"id":"W2943808099","doi":"10.1080/09546634.2019.1603361","title":"US real-world effectiveness of secukinumab for the treatment of psoriasis: 6-month analysis from the Corrona Psoriasis Registry","year":2019,"lang":"en","type":"article","venue":"Journal of Dermatological Treatment","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"","keywords":"Secukinumab; Medicine; Psoriasis; Quality of life (healthcare); Clinical endpoint; Internal medicine; Dermatology; Physical therapy; Psoriatic arthritis; Clinical trial","score_opus":0.023680204545905303,"score_gpt":0.27491816307371164,"score_spread":0.25123795852780634,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2943808099","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98369414,0.012897284,0.0001584967,0.00026258323,0.001045618,0.0010740942,0.00056363584,0.000015322807,0.00028885118],"genre_scores_gemma":[0.99442315,0.0046218326,0.00019363692,0.000021574722,0.000086736385,0.00013018164,0.00014952512,0.000018348044,0.00035502986],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99725753,0.0008476595,0.0010360938,0.0003455928,0.00015054242,0.00036257392],"domain_scores_gemma":[0.9914248,0.0061937775,0.0013363935,0.00075387734,0.00024171187,0.000049457652],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039610692,0.0004377324,0.0017530823,0.00018353121,0.00018486296,0.000018076324,0.00046809076,0.00027845852,0.0002442318],"category_scores_gemma":[0.00006391972,0.00018847422,0.0017632516,0.0004944766,0.0002348187,0.000070400914,0.000032600346,0.000113271264,0.000021358808],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011740522,0.0050305277,0.8962306,0.00006134937,0.045557033,0.00006149406,0.0010441184,0.0006260093,0.007905358,0.00066837866,0.00030821117,0.030766396],"study_design_scores_gemma":[0.016876223,0.005703397,0.8108932,0.00012310306,0.01901047,0.00011794938,0.0007768782,0.00003214023,0.13584554,0.0004477264,0.009890384,0.0002830222],"about_ca_topic_score_codex":0.0007846642,"about_ca_topic_score_gemma":0.00028967636,"teacher_disagreement_score":0.12794018,"about_ca_system_score_codex":0.000327434,"about_ca_system_score_gemma":0.00013433976,"threshold_uncertainty_score":0.76857555},"labels":[],"label_agreement":null},{"id":"W2946162325","doi":"10.1080/09546634.2019.1623368","title":"Characterizing high-burden rosacea subjects: a multivariate risk factor analysis from a global survey","year":2019,"lang":"en","type":"article","venue":"Journal of Dermatological Treatment","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Windsor Clinical Research; Western University","funders":"","keywords":"Rosacea; Medicine; Multivariate analysis; Multivariate statistics; Logistic regression; Risk factor; Quality of life (healthcare); Protective factor; Demography; Gerontology; Internal medicine; Dermatology","score_opus":0.02654028591772164,"score_gpt":0.29776543186369037,"score_spread":0.27122514594596875,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2946162325","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971098,0.00074200734,0.00017797039,0.00046859958,0.0002352971,0.00035383247,0.00072384585,0.000028415003,0.00016023181],"genre_scores_gemma":[0.9979005,0.00044146806,0.0010717637,0.00014677852,0.00013604683,0.000005307744,0.00015092919,0.000012340631,0.00013488682],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99796987,0.00036933107,0.0006375815,0.0003100735,0.000366096,0.00034705564],"domain_scores_gemma":[0.9982118,0.0003689134,0.000643718,0.00029864226,0.00014208475,0.00033483354],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015372393,0.00034086138,0.0014188751,0.00013000489,0.00009052631,0.00005556754,0.0001102206,0.00021056407,0.0006401236],"category_scores_gemma":[0.00010276623,0.00017546257,0.0007263299,0.00040625362,0.000033781034,0.0001341121,0.000038780603,0.00019036302,0.000130595],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001211016,0.0008753095,0.9834088,0.000009204182,0.007965449,0.0012093115,0.00020178502,0.00005707014,0.00083753833,0.0000050463686,0.000044419598,0.0041750534],"study_design_scores_gemma":[0.005958217,0.0015876996,0.98664576,0.000058170506,0.0031753716,0.00019287401,0.000074849115,0.0004939753,0.0011853429,0.000036264828,0.00042348282,0.00016799441],"about_ca_topic_score_codex":0.0017663824,"about_ca_topic_score_gemma":0.00005048156,"teacher_disagreement_score":0.004790078,"about_ca_system_score_codex":0.00038157514,"about_ca_system_score_gemma":0.00009513199,"threshold_uncertainty_score":0.7155156},"labels":[],"label_agreement":null},{"id":"W2947828030","doi":"10.1080/09546634.2019.1620502","title":"Review of international psoriasis guidelines for the treatment of psoriasis: recommendations for topical corticosteroid treatments","year":2019,"lang":"en","type":"editorial","venue":"Journal of Dermatological Treatment","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"LEO Pharma; National Institute for Health and Care Research","keywords":"Medicine; Psoriasis; Plaque psoriasis; Dermatology; Corticosteroid; Population; Disease; Intensive care medicine; Surgery; Internal medicine; Environmental health","score_opus":0.10088429690659054,"score_gpt":0.3779725897040562,"score_spread":0.2770882927974657,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2947828030","genre_codex":"editorial","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002473148,0.3577756,0.0005267136,0.008937198,0.6180071,0.0044462136,0.0077116573,0.00002682737,0.00009552191],"genre_scores_gemma":[0.00091735757,0.9128707,0.005080203,0.00028490316,0.07182599,0.0014120407,0.0043618595,0.00007968995,0.0031672423],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99609345,0.0003019765,0.0025812755,0.00041604205,0.00022583417,0.00038143207],"domain_scores_gemma":[0.9889768,0.0054525994,0.0028799204,0.00054708356,0.0020840738,0.00005955822],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003427853,0.0006473613,0.0023589719,0.00019973754,0.00014582444,0.00001910357,0.0005849731,0.0008217696,0.00023368621],"category_scores_gemma":[0.0012471267,0.0003309883,0.0021354954,0.00011847832,0.00013947723,0.000089622175,0.00003998353,0.00014645247,0.000015947884],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002469549,0.00385404,0.00047190144,0.0007476054,0.014157547,0.000009830619,0.00013990859,0.0000040402842,0.00016452807,0.000055688437,0.83352154,0.14440379],"study_design_scores_gemma":[0.014974342,0.007761253,0.00011806021,0.0021147234,0.008000177,0.000098774464,0.00011086782,0.000003617155,0.004960923,0.00008321079,0.96153635,0.00023772728],"about_ca_topic_score_codex":0.000023842054,"about_ca_topic_score_gemma":0.000008502388,"teacher_disagreement_score":0.55509514,"about_ca_system_score_codex":0.00054682,"about_ca_system_score_gemma":0.00043787074,"threshold_uncertainty_score":0.9999142},"labels":[],"label_agreement":null},{"id":"W2978693937","doi":"10.1080/09546634.2019.1656797","title":"Characterization of insufficient responders to anti-tumor necrosis factor therapies in patients with moderate to severe psoriasis: real-world data from the US Corrona Psoriasis Registry","year":2019,"lang":"en","type":"article","venue":"Journal of Dermatological Treatment","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"Novartis Pharmaceuticals Corporation","keywords":"Medicine; Psoriasis; Demographics; Internal medicine; Logistic regression; Tumor necrosis factor alpha; Body surface area; Dermatology; Physical therapy; Demography","score_opus":0.034188831077173486,"score_gpt":0.2590051900631193,"score_spread":0.2248163589859458,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2978693937","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963697,0.0001538467,0.00003343334,0.0007516328,0.0005012585,0.0007731715,0.00136538,0.000015429658,0.00003612367],"genre_scores_gemma":[0.9986302,0.0001760665,0.00025336436,0.0002986944,0.000026655482,0.000021591832,0.00043076044,0.000019297257,0.00014333097],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99789834,0.00045879898,0.0007319681,0.00040634873,0.00017019502,0.00033435388],"domain_scores_gemma":[0.99803627,0.00033255687,0.00068382896,0.000713615,0.00016074623,0.000072957846],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015558644,0.000336693,0.0008726467,0.0002080065,0.000099852514,0.00003750373,0.0005601438,0.00011948401,0.00015405627],"category_scores_gemma":[0.000053748296,0.00017520205,0.00012581635,0.0004144666,0.000074005824,0.00018405459,0.00012481521,0.00015019036,0.00007299998],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009259192,0.0017099538,0.96774244,0.000008141878,0.0008899373,0.000038803995,0.0014577535,0.0001134134,0.014190488,0.000024751567,0.00019228757,0.0043728333],"study_design_scores_gemma":[0.0058526527,0.0015753458,0.97581005,0.00013189316,0.00019811543,0.00002282105,0.0002739174,0.0000060302423,0.014136456,0.000010442928,0.0017739194,0.00020837737],"about_ca_topic_score_codex":0.00020847018,"about_ca_topic_score_gemma":0.00020936487,"teacher_disagreement_score":0.008067585,"about_ca_system_score_codex":0.0001943346,"about_ca_system_score_gemma":0.00011281502,"threshold_uncertainty_score":0.7144532},"labels":[],"label_agreement":null},{"id":"W2979619560","doi":"10.1080/09546634.2019.1675854","title":"The potential role of cannabinoids in dermatology","year":2019,"lang":"en","type":"review","venue":"Journal of Dermatological Treatment","topic":"Cannabis and Cannabinoid Research","field":"Medicine","cited_by":115,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Acne; Atopic dermatitis; Psoriasis; Dermatology; Cannabis; Antipruritic; Synthetic cannabinoids; Skin cancer; Cannabinoid; Cancer; Psychiatry","score_opus":0.04341714290984188,"score_gpt":0.3689631632026301,"score_spread":0.32554602029278823,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979619560","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001630172,0.99412817,0.0000020089713,0.0025086778,0.00024050895,0.0008842139,0.000018443428,0.000005217938,0.0005825801],"genre_scores_gemma":[0.0024588353,0.99620664,0.00004213982,0.000028967892,0.00010170256,0.00005518881,0.000012130142,0.000028135546,0.0010662882],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9964376,0.00045562309,0.0017997123,0.00023197941,0.00057364965,0.00050140586],"domain_scores_gemma":[0.99792874,0.00012295115,0.0010355829,0.00041722128,0.00026366382,0.00023181991],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002783587,0.0003982759,0.0034749925,0.0003812494,0.0000614494,0.000027358594,0.00036153628,0.0004977931,0.0000639271],"category_scores_gemma":[0.00014056587,0.00017477978,0.0015847338,0.00034520178,0.00024164138,0.000040092775,0.000093537645,0.00073429605,0.000027160006],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002848941,0.0010203884,0.0007755686,0.004100911,0.00087098044,0.0042187567,0.000045355853,0.0000033424487,0.0000091222455,0.00035502212,0.005127047,0.9831886],"study_design_scores_gemma":[0.0015455645,0.0009403399,0.00041201897,0.0020940097,0.0010894163,0.029883508,0.00011879337,0.000010044022,0.000044002307,0.00011784414,0.96360874,0.00013569133],"about_ca_topic_score_codex":0.00002279731,"about_ca_topic_score_gemma":0.000008604169,"teacher_disagreement_score":0.9830529,"about_ca_system_score_codex":0.00051838194,"about_ca_system_score_gemma":0.0016249421,"threshold_uncertainty_score":0.71273124},"labels":[],"label_agreement":null},{"id":"W2980410436","doi":"10.1080/09546634.2019.1679336","title":"Consistent response to guselkumab treatment between Hispanic and non-Hispanic patients with psoriasis: an analysis from VOYAGE 1 and VOYAGE 2","year":2019,"lang":"en","type":"article","venue":"Journal of Dermatological Treatment","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health; Queen's University","funders":"","keywords":"Medicine; Dermatology Life Quality Index; Adalimumab; Psoriasis; Internal medicine; Placebo; Psoriasis Area and Severity Index; Population; Dermatology; Adverse effect; Confidence interval; Gastroenterology; Disease; Pathology","score_opus":0.014621732709655786,"score_gpt":0.23792431000547995,"score_spread":0.22330257729582417,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980410436","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961402,0.002114811,0.00004162664,0.0004241478,0.00018622878,0.0006731746,0.00035430296,0.00002904131,0.00003646883],"genre_scores_gemma":[0.9983443,0.00033897784,0.00059637276,0.000096818905,0.00003475311,0.000035598307,0.00019514652,0.000023954099,0.00033408226],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997428,0.0006726878,0.00072340935,0.00058022223,0.00014036718,0.00045531229],"domain_scores_gemma":[0.9979729,0.0006926145,0.00047813824,0.00045951607,0.00013486348,0.00026194204],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00019484077,0.00054039015,0.0015418963,0.00040343674,0.0001845286,0.00006198882,0.00017747143,0.00031621556,0.00023591243],"category_scores_gemma":[0.000034661538,0.0003087298,0.00032206264,0.00028139405,0.000111924244,0.00018402054,0.000063755855,0.0001309493,0.00009878914],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00641953,0.0015252089,0.96821755,0.0000059679915,0.00971224,0.0001979402,0.00086116133,0.00001311618,0.0028713553,0.000009346797,0.000041930074,0.0101246275],"study_design_scores_gemma":[0.014379579,0.014523215,0.9572893,0.000043444557,0.006927014,0.000109461165,0.00035756023,0.0000047550825,0.0039218077,0.000021041238,0.0020776086,0.00034525167],"about_ca_topic_score_codex":0.00010283286,"about_ca_topic_score_gemma":0.00005580655,"teacher_disagreement_score":0.012998005,"about_ca_system_score_codex":0.00038339576,"about_ca_system_score_gemma":0.000091067515,"threshold_uncertainty_score":0.99993646},"labels":[],"label_agreement":null},{"id":"W2981124378","doi":"10.1080/09546634.2019.1682501","title":"Adverse reactions associated with the esthetic use of soft tissue fillers and neurotoxins: a 53-year retrospective analysis of MedEffect™, Health Canada’s reporting database","year":2019,"lang":"en","type":"article","venue":"Journal of Dermatological Treatment","topic":"Facial Rejuvenation and Surgery Techniques","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal; GDI Integrated Facility Services (Canada); Victoria Park; Centre Hospitalier de l’Université de Montréal; McGill University","funders":"","keywords":"Medicine; Soft tissue; Adverse effect; Database; Drug reaction; Brain tissue; Surgery; Internal medicine; Psychiatry; Drug","score_opus":0.04077285448652362,"score_gpt":0.30804392235239136,"score_spread":0.26727106786586774,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2981124378","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99450964,0.00006395429,0.00006826055,0.004812685,0.000021321497,0.0003784216,0.00003659164,0.0000093847375,0.0000997307],"genre_scores_gemma":[0.9990623,0.00013542623,0.00034918013,0.00035984206,0.0000018803341,0.0000048855004,0.000015780157,0.0000053266895,0.000065371256],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99843633,0.00018001188,0.00079276745,0.00011197256,0.0003619767,0.00011695678],"domain_scores_gemma":[0.99705064,0.00042039747,0.0020204324,0.00016677215,0.0002312828,0.000110468216],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037932262,0.000104605955,0.00079873303,0.00016955772,0.00004781755,0.0000049356045,0.00003244309,0.000041993837,0.0000372374],"category_scores_gemma":[0.0011284468,0.000052095158,0.00014150272,0.00037765145,0.00006419228,0.000060228893,0.000011555972,0.00013346152,1.2852938e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003169279,0.00054834917,0.9920122,0.000030309071,0.002127162,0.0006522088,0.0003288705,0.00019088808,0.0009860075,0.000120250086,0.0014597003,0.0012271145],"study_design_scores_gemma":[0.0011338724,0.0018143815,0.9872492,0.0002510023,0.00092545815,0.0005642208,0.00042126092,0.00043759236,0.0025524197,0.0000067684664,0.004565576,0.000078244855],"about_ca_topic_score_codex":0.009044493,"about_ca_topic_score_gemma":0.011854301,"teacher_disagreement_score":0.0047630095,"about_ca_system_score_codex":0.0003001104,"about_ca_system_score_gemma":0.00047711772,"threshold_uncertainty_score":0.99755436},"labels":[],"label_agreement":null},{"id":"W2987717944","doi":"10.1080/09546634.2019.1687821","title":"Fractional CO<sub>2</sub> laser is as effective as pulsed dye laser for the treatment of hypertrophic scars","year":2019,"lang":"en","type":"article","venue":"Journal of Dermatological Treatment","topic":"Dermatologic Treatments and Research","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Scars; Hypertrophic scars; Dye laser; Laser; Hypertrophic scar; Surgery; Pulse (music); Optics","score_opus":0.026417809179209842,"score_gpt":0.3358724853790428,"score_spread":0.30945467619983297,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2987717944","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9881581,0.0018817765,0.000028810533,0.0060844007,0.00027795916,0.002326329,0.00006451839,0.000019282143,0.0011587902],"genre_scores_gemma":[0.9946003,0.0035575584,0.00016171613,0.0005074967,0.0001273184,0.00022698959,0.000027474995,0.000026940434,0.00076421315],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9976381,0.0001823346,0.0007082221,0.00032588324,0.0006909074,0.00045452433],"domain_scores_gemma":[0.9969882,0.0015119897,0.00046403016,0.00036584563,0.00037598054,0.000293961],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014819989,0.00039812576,0.0011800551,0.00018298966,0.00017799741,0.0000343878,0.00014828662,0.0002512702,0.00041208407],"category_scores_gemma":[0.00007627752,0.00016982548,0.0009854108,0.00017708653,0.00020247414,0.00010745155,0.00001999461,0.00019312261,0.00029389604],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04024911,0.05748966,0.58566034,0.0005375155,0.03133689,0.012827642,0.002018485,0.0009610408,0.04264352,0.00060791854,0.013254765,0.2124131],"study_design_scores_gemma":[0.037789684,0.03751213,0.108631425,0.0002246183,0.0022979109,0.020823175,0.0007074336,0.00035652771,0.7511081,0.0010022944,0.039156932,0.00038978367],"about_ca_topic_score_codex":0.000017901923,"about_ca_topic_score_gemma":0.0000012750585,"teacher_disagreement_score":0.70846456,"about_ca_system_score_codex":0.0005456605,"about_ca_system_score_gemma":0.00027819435,"threshold_uncertainty_score":0.6925282},"labels":[],"label_agreement":null},{"id":"W2991340463","doi":"10.1080/09546634.2019.1688755","title":"Meta-analysis of photobiomodulation for the treatment of androgenetic alopecia","year":2019,"lang":"en","type":"review","venue":"Journal of Dermatological Treatment","topic":"Hair Growth and Disorders","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mediprobe Research (Canada)","funders":"","keywords":"Medicine; Meta-analysis; Subgroup analysis; Adverse effect; Intense pulsed light; Significant difference; Treatment effect; Dermatology; Safety profile; Internal medicine; Surgery; Traditional medicine","score_opus":0.4128497960390892,"score_gpt":0.43823159720045823,"score_spread":0.02538180116136901,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2991340463","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0008953414,0.9965789,0.00025031005,0.0001446127,0.00006639234,0.0017753915,0.00019753646,0.000003363468,0.000088161665],"genre_scores_gemma":[0.0075855115,0.9914345,0.0005685138,0.000022444527,0.000032288757,0.00011298333,0.00010560569,0.000016367096,0.00012177673],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99755174,0.00016074273,0.0015858344,0.00019797483,0.00032093984,0.00018277402],"domain_scores_gemma":[0.9966572,0.0009414324,0.0016704934,0.00039887824,0.00021680586,0.0001152077],"candidate_categories":["metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.00014084697,0.00038418963,0.0069838734,0.00041130197,0.000032445587,0.00000755145,0.00012921785,0.00022777775,0.00019772806],"category_scores_gemma":[0.00003695873,0.0001426193,0.009974994,0.0004911728,0.000076761455,0.000021656157,0.000008327514,0.000058830683,0.000004816256],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002515618,0.0031132533,0.0005872687,0.0024419518,0.6688688,0.000069170586,0.00013887501,0.00011399616,0.000002201363,0.00004214512,0.000073203366,0.3242976],"study_design_scores_gemma":[0.0013736682,0.0026583234,0.00013533172,0.00011133149,0.6565731,0.00020935814,0.00002710612,0.000058475667,0.000056404635,0.000011771343,0.3387048,0.000080305384],"about_ca_topic_score_codex":0.0000077172745,"about_ca_topic_score_gemma":0.000005954246,"teacher_disagreement_score":0.3386316,"about_ca_system_score_codex":0.00018629729,"about_ca_system_score_gemma":0.00026375393,"threshold_uncertainty_score":0.99993986},"labels":[],"label_agreement":null},{"id":"W3003638259","doi":"10.1080/09546634.2020.1724250","title":"Topical treatment of psoriasis: questionnaire results on topical therapy as long-term continuous treatment and use on specific body sites","year":2020,"lang":"en","type":"article","venue":"Journal of Dermatological Treatment","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Innovaderm (Canada)","funders":"Cilag; LEO Pharma; Bausch Health; Bristol-Myers Squibb; Eli Lilly and Company; Galderma; Sanofi Genzyme; Incyte; Dermira; Regeneron Pharmaceuticals; Celgene; Valeant Pharmaceuticals International; Sanofi; Amgen; Pfizer","keywords":"Medicine; Psoriasis; Dermatology; Term (time)","score_opus":0.061345816132115996,"score_gpt":0.2869051222724769,"score_spread":0.2255593061403609,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3003638259","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98661643,0.0086314045,0.000010323021,0.0034950103,0.00036477266,0.00054146996,0.000088689616,0.00004250159,0.00020937917],"genre_scores_gemma":[0.9820898,0.016861284,0.00012390729,0.00022169479,0.0002066808,0.000035884754,0.00007297333,0.000017942828,0.0003698059],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976558,0.0004962779,0.00089936296,0.0004676524,0.000117559764,0.00036331525],"domain_scores_gemma":[0.9983423,0.0006055686,0.00047516453,0.00030025461,0.00009352807,0.00018322034],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000055319284,0.00053370907,0.0012224937,0.00011999077,0.00015042053,0.00004344691,0.0001384559,0.00036801994,0.0001243072],"category_scores_gemma":[0.00008124051,0.00029148255,0.0005195547,0.000103819126,0.00018458707,0.00009403072,0.000018929066,0.00012218804,0.000096777025],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.040899336,0.01923449,0.47917938,0.000024380433,0.0054148533,0.0045140632,0.003005077,0.000016988999,0.02018508,0.0020226673,0.00072098925,0.4247827],"study_design_scores_gemma":[0.043974068,0.11091617,0.5837632,0.00019299038,0.00078609976,0.0023215362,0.00018306072,0.000002410285,0.2320947,0.00013653236,0.025094658,0.0005345586],"about_ca_topic_score_codex":0.000019745547,"about_ca_topic_score_gemma":0.0000055686546,"teacher_disagreement_score":0.42424813,"about_ca_system_score_codex":0.00029732555,"about_ca_system_score_gemma":0.00006827715,"threshold_uncertainty_score":0.99995375},"labels":[],"label_agreement":null},{"id":"W3004935569","doi":"10.1080/09546634.2020.1720586","title":"Characterization of insufficient responders to ustekinumab in patients with moderate-to-severe psoriasis in the US Corrona Psoriasis Registry","year":2020,"lang":"en","type":"article","venue":"Journal of Dermatological Treatment","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"","keywords":"Ustekinumab; Medicine; Psoriasis; Plaque psoriasis; Logistic regression; Internal medicine; Demographics; Dermatology; Disease; Adalimumab; Demography","score_opus":0.022571259567142524,"score_gpt":0.23226676470145394,"score_spread":0.2096955051343114,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3004935569","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969427,0.00011929916,0.00008919806,0.0018658562,0.00018544146,0.0006195361,0.00009385334,0.000008539262,0.00007556817],"genre_scores_gemma":[0.99894696,0.00005222,0.00018367682,0.00065610406,0.000020370058,0.000035453097,0.00006969569,0.000011353269,0.000024183688],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998083,0.00049390923,0.0007164549,0.00025913937,0.00015316054,0.00029433685],"domain_scores_gemma":[0.99904037,0.00015838217,0.00039472547,0.00020880804,0.00012125913,0.00007648392],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015522349,0.00026151817,0.0006654122,0.00021780588,0.00006398212,0.00001773614,0.00028588207,0.00018702897,0.00005289726],"category_scores_gemma":[0.000103487946,0.00014199303,0.00013165492,0.00055358815,0.00004805845,0.00009272773,0.00003848919,0.00016529954,0.00003056435],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.038121678,0.006398933,0.9132055,0.000042938944,0.00067706825,0.0005560949,0.011750634,0.0020931286,0.010328974,0.00015346085,0.00035129683,0.0163203],"study_design_scores_gemma":[0.013423796,0.0053783203,0.96362865,0.00011195578,0.00018863301,0.00014698708,0.00072145736,0.000010078337,0.013909047,0.000013387291,0.0022217517,0.0002459122],"about_ca_topic_score_codex":0.000015076801,"about_ca_topic_score_gemma":0.000018393712,"teacher_disagreement_score":0.050423183,"about_ca_system_score_codex":0.00019060833,"about_ca_system_score_gemma":0.00009323293,"threshold_uncertainty_score":0.57903075},"labels":[],"label_agreement":null},{"id":"W3007535309","doi":"10.1080/09546634.2020.1729335","title":"Long-term topical management of psoriasis: the road ahead","year":2020,"lang":"en","type":"article","venue":"Journal of Dermatological Treatment","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; Queen's University","funders":"LEO Pharma Research Foundation","keywords":"Medicine; Psoriasis; Context (archaeology); Terminology; Intensive care medicine; Expert opinion; Dermatology","score_opus":0.050516262711469605,"score_gpt":0.31762364054293424,"score_spread":0.26710737783146465,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3007535309","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9675153,0.004464809,0.00015304559,0.025093526,0.0001352268,0.00026856337,0.0000036910942,0.000016209906,0.0023496167],"genre_scores_gemma":[0.9970925,0.0010186285,0.0004617913,0.0012543659,0.00009538044,0.000008337524,0.0000029026771,0.0000055340693,0.000060559254],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99877805,0.000103767765,0.00056120707,0.0001191064,0.000269983,0.00016791999],"domain_scores_gemma":[0.99921185,0.00008456474,0.00024338403,0.00016451631,0.00007018119,0.00022547648],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000051446514,0.00014619493,0.000559278,0.000031185107,0.000048493173,0.000008899856,0.00015439215,0.00008605181,0.00019085337],"category_scores_gemma":[0.000038719183,0.000067724286,0.00037149026,0.000102942795,0.00012878996,0.000043371947,0.000040994113,0.00013801115,0.000027145432],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020636804,0.0023484766,0.92885965,0.0003281681,0.0023119785,0.018774662,0.00034068187,0.000009083469,0.00006108459,0.0010246885,0.006330304,0.037547566],"study_design_scores_gemma":[0.004345141,0.0010190923,0.983417,0.00016132557,0.0011333006,0.004971263,0.00023172594,0.000022731854,0.0020318776,0.00020627298,0.0023746889,0.00008558067],"about_ca_topic_score_codex":4.5580097e-7,"about_ca_topic_score_gemma":1.6621625e-7,"teacher_disagreement_score":0.054557376,"about_ca_system_score_codex":0.00003664886,"about_ca_system_score_gemma":0.000041139345,"threshold_uncertainty_score":0.27617162},"labels":[],"label_agreement":null},{"id":"W3014639863","doi":"10.1080/09546634.2020.1749547","title":"Efficacy of non-surgical treatments for androgenetic alopecia in men and women: a systematic review with network meta-analyses, and an assessment of evidence quality","year":2020,"lang":"en","type":"review","venue":"Journal of Dermatological Treatment","topic":"Hair Growth and Disorders","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mediprobe Research (Canada)","funders":"","keywords":"Medicine; Minoxidil; Randomized controlled trial; Bimatoprost; Finasteride; Meta-analysis; Randomization; Quality of evidence; Internal medicine; Urology; Surgery; Latanoprost","score_opus":0.41185573417425464,"score_gpt":0.5435135726847296,"score_spread":0.1316578385104749,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3014639863","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0019900557,0.9931996,0.000077424804,0.0001667855,0.000009584188,0.004473328,0.000030891093,0.0000041569824,0.000048177375],"genre_scores_gemma":[0.009039464,0.98713094,0.0032026418,0.000057404875,0.000025141426,0.00049248786,0.000021555383,0.00002119033,0.000009169563],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.994649,0.0011719827,0.002955021,0.00039464136,0.0005221012,0.00030725586],"domain_scores_gemma":[0.9950153,0.0015991706,0.0024111469,0.00034357377,0.0001570295,0.00047373743],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009883565,0.0005740614,0.012298063,0.00014596235,0.000032520067,0.000015877771,0.00014524869,0.00018782658,0.000019576713],"category_scores_gemma":[0.00029020882,0.00023121767,0.0010792734,0.00039289097,0.00012676803,0.00007727228,0.000039166316,0.00018636143,3.4978052e-7],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009780673,0.0030330832,0.0031603065,0.9105786,0.041833743,0.0017527697,0.00021880865,0.000011041485,7.8593e-7,0.000034871795,0.000036270565,0.038361628],"study_design_scores_gemma":[0.018079525,0.023503132,0.002931648,0.5408332,0.39775395,0.008522416,0.00032254326,0.00009644233,0.000004867255,0.00005868678,0.007161337,0.00073229434],"about_ca_topic_score_codex":0.0000061522614,"about_ca_topic_score_gemma":0.0000025577392,"teacher_disagreement_score":0.36974546,"about_ca_system_score_codex":0.0002525605,"about_ca_system_score_gemma":0.0004906146,"threshold_uncertainty_score":0.9428783},"labels":[],"label_agreement":null},{"id":"W3021421518","doi":"10.1080/09546634.2020.1747590","title":"Disease activity and treatment efficacy using patient-level Psoriasis Area and Severity Index scores from tildrakizumab phase 3 clinical trials","year":2020,"lang":"en","type":"article","venue":"Journal of Dermatological Treatment","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; Université Laval; Centre de Recherche Dermatologique du Québec Métropolitain; Hôtel-Dieu de Québec","funders":"Merck Sharp and Dohme","keywords":"Medicine; Psoriasis Area and Severity Index; Psoriasis; Internal medicine; Dermatology Life Quality Index; Clinical trial; Placebo; Severity of illness; Plaque psoriasis; Gastroenterology; Quality of life (healthcare); Dermatology; Physical therapy; Pathology","score_opus":0.26164119865088536,"score_gpt":0.3907763029369532,"score_spread":0.12913510428606784,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3021421518","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9893887,0.0074843257,0.00022964198,0.0009847209,0.00041974298,0.00056392926,0.00088597817,0.000032425203,0.0000105482995],"genre_scores_gemma":[0.99558073,0.0034682227,0.0005337373,0.00016023201,0.00015175638,0.000016122445,0.000061721476,0.00001698535,0.0000104917135],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99590766,0.0019201962,0.0012221714,0.00050207967,0.0001060775,0.00034181983],"domain_scores_gemma":[0.99634475,0.0019876766,0.00096560037,0.0002145346,0.00007513799,0.000412307],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00028744718,0.0004893447,0.0018384461,0.00008774849,0.00024136997,0.000056008645,0.00011722274,0.00034684705,0.0001562637],"category_scores_gemma":[0.0006733043,0.00028763368,0.00061222905,0.00010338148,0.00025800354,0.0001808083,0.00008219656,0.00020253894,0.0000136067865],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02421431,0.006962169,0.24987605,0.000012881606,0.004621017,0.0014020182,0.00071435753,0.00001144172,0.004758487,0.000011541692,0.0001742344,0.7072415],"study_design_scores_gemma":[0.114136666,0.016216129,0.81499016,0.00019705074,0.009246942,0.0012866182,0.00044689112,0.00060021045,0.03460491,0.00035184243,0.006872207,0.0010503983],"about_ca_topic_score_codex":0.00006920704,"about_ca_topic_score_gemma":0.000008101129,"teacher_disagreement_score":0.70619106,"about_ca_system_score_codex":0.00016007958,"about_ca_system_score_gemma":0.00017822317,"threshold_uncertainty_score":0.99995756},"labels":[],"label_agreement":null},{"id":"W3034088199","doi":"10.1080/09546634.2020.1781757","title":"The application of medical scale in the treatment of plantar warts: analysis and prospect","year":2020,"lang":"en","type":"review","venue":"Journal of Dermatological Treatment","topic":"Genital Health and Disease","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health","funders":"","keywords":"Plantar warts; Medicine; Cryotherapy; Adverse effect; Conjoint analysis; Quality of life (healthcare); Physical therapy; Dermatology; Surgery; Internal medicine","score_opus":0.050695712007191834,"score_gpt":0.3981674252087829,"score_spread":0.3474717132015911,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3034088199","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009608256,0.98717654,0.000018588795,0.0020435124,0.000020503127,0.0010132927,0.00004333498,0.00000288074,0.00007310928],"genre_scores_gemma":[0.070874244,0.92881316,0.00008659901,0.000045911485,0.000055509136,0.00008258351,0.000031593423,0.000005533324,0.0000048827565],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99761283,0.00026473543,0.0012106926,0.00015532601,0.000594131,0.0001623007],"domain_scores_gemma":[0.99805117,0.0005859757,0.00078072504,0.00022485257,0.00005390741,0.0003033825],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023876272,0.00022767614,0.002100251,0.00013737571,0.000046954017,0.000008643715,0.0001602966,0.00017735429,0.000011694666],"category_scores_gemma":[0.00006696359,0.000077110904,0.000813946,0.00044159716,0.0001359519,0.000014232535,0.000013463564,0.00015387141,0.0000023303762],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047452125,0.0029528642,0.023152085,0.0028564301,0.0012615356,0.00079889334,0.0003200035,4.068714e-7,1.03427666e-7,0.00008985067,0.000048109134,0.9680452],"study_design_scores_gemma":[0.004870229,0.007909903,0.016563714,0.0015772369,0.029071705,0.0056658415,0.00046660984,0.00012087639,0.000022799022,0.00019417123,0.933343,0.00019390823],"about_ca_topic_score_codex":0.000034383174,"about_ca_topic_score_gemma":0.00003659139,"teacher_disagreement_score":0.9678513,"about_ca_system_score_codex":0.00016853824,"about_ca_system_score_gemma":0.0004091145,"threshold_uncertainty_score":0.31444913},"labels":[],"label_agreement":null},{"id":"W3041882876","doi":"10.1080/09546634.2020.1795061","title":"A systematic review of antipsychotic agents for primary delusional infestation","year":2020,"lang":"en","type":"review","venue":"Journal of Dermatological Treatment","topic":"Body Image and Dysmorphia Studies","field":"Psychology","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Ottawa Hospital; Queen's University","funders":"","keywords":"Medicine; Risperidone; PsycINFO; Olanzapine; Antipsychotic; MEDLINE; Psychiatry; Atypical antipsychotic; Pimozide; Systematic review; Schizophrenia (object-oriented programming); Haloperidol; Internal medicine","score_opus":0.121951001454607,"score_gpt":0.43242273202967957,"score_spread":0.3104717305750726,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3041882876","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000043619425,0.99556607,0.00039241635,0.00037459357,0.00042933685,0.0025884488,0.00009851979,0.000011437838,0.0005347867],"genre_scores_gemma":[0.000011162303,0.99764264,0.0011357235,0.000585106,0.000097252,0.00032871176,0.00006717768,0.000026410524,0.00010579536],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99575335,0.0006013412,0.0028028456,0.00025247075,0.00035599156,0.00023399576],"domain_scores_gemma":[0.9946331,0.0011545959,0.0035339326,0.00026465286,0.00028047076,0.00013329122],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032299967,0.00045348392,0.0058601727,0.00015335498,0.00006085598,0.000013410986,0.00029179247,0.00021522141,0.00012204975],"category_scores_gemma":[0.00038422353,0.00023687755,0.0019367713,0.00023392182,0.00007003801,0.000058303038,0.000045756016,0.00019763516,0.000066075336],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005223237,0.0007562055,0.000012647115,0.92912126,0.0038576566,0.0008596874,0.000107491105,4.153962e-8,5.5616447e-8,0.00037009903,0.007859326,0.057003293],"study_design_scores_gemma":[0.001103665,0.0010121586,0.00004337173,0.61816275,0.014385523,0.005005523,0.000035061174,4.5609775e-7,2.1518494e-7,0.00013830894,0.3598813,0.00023166683],"about_ca_topic_score_codex":5.671166e-7,"about_ca_topic_score_gemma":9.726867e-8,"teacher_disagreement_score":0.352022,"about_ca_system_score_codex":0.00019600058,"about_ca_system_score_gemma":0.00021278088,"threshold_uncertainty_score":0.9659586},"labels":[],"label_agreement":null},{"id":"W3042689359","doi":"10.1080/09546634.2020.1782817","title":"Continuous treatment with guselkumab maintains clinical responses through 4 years in patients with moderate-to-severe psoriasis: results from VOYAGE 1","year":2020,"lang":"en","type":"article","venue":"Journal of Dermatological Treatment","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"Janssen Research and Development","keywords":"Medicine; Psoriasis; Internal medicine; Placebo; Clinical trial; Dermatology; Adalimumab; Gastroenterology; Surgery; Rheumatoid arthritis","score_opus":0.04617964588141407,"score_gpt":0.2791858588932267,"score_spread":0.23300621301181265,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3042689359","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953486,0.0007997008,0.00006701467,0.0020344008,0.00021919714,0.0006967137,0.0005979817,0.000045514033,0.00019089766],"genre_scores_gemma":[0.9963555,0.00043186836,0.0021665944,0.0005359341,0.00007996146,0.000039290288,0.00018423938,0.000030563406,0.00017609543],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967093,0.0008610656,0.0011966536,0.0005754862,0.00015724893,0.00050026295],"domain_scores_gemma":[0.9979755,0.0007739381,0.0005955462,0.0003285401,0.00014134822,0.0001851187],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00014475019,0.00049985445,0.0014238381,0.00010724649,0.000108422064,0.000040319726,0.00025150977,0.00034573092,0.00009164812],"category_scores_gemma":[0.0001364555,0.00026955068,0.0002895886,0.00024721178,0.00014102926,0.00016488967,0.00004545708,0.00024356374,0.0001603864],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.20098029,0.0074255774,0.7461234,0.000005535631,0.0046007303,0.0048291255,0.0037308538,0.00021649773,0.00012123172,0.000050703642,0.0012721702,0.030643886],"study_design_scores_gemma":[0.11209108,0.04509685,0.8169099,0.00018605207,0.0012962321,0.00033733726,0.0009088079,0.0000049721925,0.0037048017,0.000094584226,0.018704232,0.0006651173],"about_ca_topic_score_codex":0.00008537079,"about_ca_topic_score_gemma":0.00006535228,"teacher_disagreement_score":0.088889204,"about_ca_system_score_codex":0.0003262148,"about_ca_system_score_gemma":0.0002139689,"threshold_uncertainty_score":0.9999757},"labels":[],"label_agreement":null},{"id":"W3043733200","doi":"10.1080/09546634.2020.1793891","title":"Cost per responder analysis of guselkumab versus targeted therapies in the treatment of moderate to severe plaque psoriasis in Germany","year":2020,"lang":"en","type":"article","venue":"Journal of Dermatological Treatment","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Medicine; Secukinumab; Psoriasis Area and Severity Index; Psoriasis; Adalimumab; Dermatology; Adverse effect; Internal medicine; Psoriatic arthritis; Rheumatoid arthritis","score_opus":0.07257574718631102,"score_gpt":0.3027416133475172,"score_spread":0.23016586616120618,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3043733200","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915764,0.0050266334,0.00003457484,0.002526361,0.0001441486,0.00046199927,0.00012617934,0.00000778085,0.00009597704],"genre_scores_gemma":[0.9972334,0.0021786103,0.00028402658,0.00015188567,0.000019088153,0.000054385902,0.000037664096,0.000009596177,0.00003132438],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975766,0.00082550035,0.0009316991,0.0002464745,0.00011791508,0.00030183035],"domain_scores_gemma":[0.9984558,0.0007303369,0.00042601678,0.00023706006,0.00009370953,0.000057051395],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016733371,0.000311289,0.001292479,0.00046333668,0.000055390643,0.00001142612,0.00025289264,0.00022566695,0.00026322724],"category_scores_gemma":[0.00004520118,0.00016361526,0.0005655388,0.00080722367,0.00008249319,0.000075004995,0.00001914523,0.0001100936,0.00001927545],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.15982257,0.028922724,0.38883433,0.000083666135,0.07015092,0.0033940137,0.17342772,0.02336476,0.072460465,0.00094984233,0.0009840024,0.07760498],"study_design_scores_gemma":[0.07465025,0.024528638,0.7205968,0.00010624999,0.010973137,0.00043337228,0.013952548,0.00026585397,0.13629493,0.00018077792,0.017085414,0.0009320117],"about_ca_topic_score_codex":0.000062174455,"about_ca_topic_score_gemma":0.00013818165,"teacher_disagreement_score":0.33176246,"about_ca_system_score_codex":0.00022850241,"about_ca_system_score_gemma":0.0000858726,"threshold_uncertainty_score":0.66720366},"labels":[],"label_agreement":null},{"id":"W3044999761","doi":"10.1080/09546634.2020.1801973","title":"Antimalarial therapy for granuloma annulare: a systematic review","year":2020,"lang":"en","type":"review","venue":"Journal of Dermatological Treatment","topic":"Skin Diseases and Diabetes","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health","funders":"","keywords":"Granuloma annulare; Medicine; Dermatology","score_opus":0.08982683859480238,"score_gpt":0.39812284711507157,"score_spread":0.30829600852026917,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3044999761","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000022555092,0.99063224,0.000014165861,0.00058954046,0.00017400371,0.008438634,0.00007400437,0.000023593182,0.000031243067],"genre_scores_gemma":[0.00008155497,0.99796855,0.00036369637,0.00062459114,0.00029831886,0.00055386074,0.000055174936,0.000038935832,0.000015293284],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99674743,0.0003963143,0.0019431058,0.00026871284,0.0003878164,0.0002566227],"domain_scores_gemma":[0.9968934,0.0006269064,0.0015631536,0.00032573505,0.000204138,0.00038665015],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002213686,0.0005437285,0.008481675,0.000111307745,0.000053061503,0.00003815704,0.00020886121,0.00021184214,0.0000600008],"category_scores_gemma":[0.0007366096,0.00023747684,0.0037338238,0.00021564431,0.00003228501,0.000043278356,0.000021995333,0.00019548307,0.000025725973],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018762826,0.0022928813,0.000100214325,0.89199543,0.00414162,0.004222863,0.000013892624,1.4478969e-8,5.4891085e-8,0.000019555084,0.002292372,0.09473348],"study_design_scores_gemma":[0.0038526903,0.0054609054,0.000016193817,0.49703395,0.03377484,0.0063562538,0.00001290645,0.0000013394238,8.491265e-7,0.000029724322,0.45324087,0.00021946056],"about_ca_topic_score_codex":3.4028778e-7,"about_ca_topic_score_gemma":3.158844e-8,"teacher_disagreement_score":0.4509485,"about_ca_system_score_codex":0.00017609757,"about_ca_system_score_gemma":0.0004244669,"threshold_uncertainty_score":0.96840245},"labels":[],"label_agreement":null},{"id":"W3046057178","doi":"10.1080/09546634.2020.1800571","title":"Health state utility values derived from EQ-5D in psoriatic patients: a systematic review and meta-analysis","year":2020,"lang":"en","type":"review","venue":"Journal of Dermatological Treatment","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Aging","funders":"","keywords":"Psoriasis; Psoriatic arthritis; Medicine; EQ-5D; Psoriasis Area and Severity Index; Dermatology Life Quality Index; Dermatology; Meta-analysis; Quality of life (healthcare); Plaque psoriasis; Physical therapy; Internal medicine; Health related quality of life; Disease","score_opus":0.6690066283858982,"score_gpt":0.47750791437737444,"score_spread":0.19149871400852375,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3046057178","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000701156,0.98261726,0.00032671477,0.011735542,0.000093024,0.0035180105,0.0016051787,0.000013980322,0.00002014938],"genre_scores_gemma":[0.000362324,0.9928825,0.0014730952,0.0047860835,0.00003012321,0.00029992548,0.00011981015,0.0000282939,0.000017858718],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9777078,0.0046734903,0.016282935,0.00070924015,0.00021547858,0.00041104926],"domain_scores_gemma":[0.97765523,0.002986167,0.018186593,0.0005928433,0.00010586696,0.0004733188],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.007557739,0.0006744891,0.031232571,0.00057028607,0.00009631919,0.00009798722,0.0004030895,0.00022962189,0.0002897194],"category_scores_gemma":[0.0036856416,0.00045791318,0.003274695,0.00060270337,0.000059619186,0.00025157022,0.00007657095,0.0003800194,0.00019432476],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000011047099,0.0010198765,0.0019290737,0.781544,0.2101508,0.000073628755,0.0009076027,0.0000054640027,2.2884064e-10,0.0002475839,0.0010589565,0.0030519457],"study_design_scores_gemma":[0.0028131397,0.0011214983,0.002181065,0.05845451,0.80492306,0.00017185099,0.0002519168,0.00022444979,3.414099e-8,0.0063154064,0.12192653,0.0016165109],"about_ca_topic_score_codex":0.00023811098,"about_ca_topic_score_gemma":0.00006229769,"teacher_disagreement_score":0.7230895,"about_ca_system_score_codex":0.0015592345,"about_ca_system_score_gemma":0.00037785544,"threshold_uncertainty_score":0.9997873},"labels":[],"label_agreement":null},{"id":"W3049127020","doi":"10.1080/09546634.2020.1810607","title":"Onychomycosis in children – review on treatment and management strategies","year":2020,"lang":"en","type":"review","venue":"Journal of Dermatological Treatment","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; Mediprobe Research (Canada); Women's College Hospital; University of Toronto","funders":"","keywords":"Medicine; Terbinafine; Itraconazole; Dermatology; Fluconazole; Dermatophyte; Antifungal; Venereology; Griseofulvin; Dosing; Nail disease; Pharmacology; Paronychia","score_opus":0.06830569727389431,"score_gpt":0.38623893664439507,"score_spread":0.3179332393705008,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3049127020","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0004997667,0.99513227,9.013675e-7,0.0006856073,0.00004731423,0.0025375532,0.00006158125,0.0000183696,0.0010166147],"genre_scores_gemma":[0.0005628327,0.9984328,0.00027177157,0.00027286203,0.00007021115,0.00020162776,0.00008868339,0.000033805805,0.00006540159],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99755675,0.00021151784,0.0012025047,0.00042571934,0.00030311104,0.00030038957],"domain_scores_gemma":[0.9984414,0.00011948385,0.00067864364,0.00029161802,0.00003240439,0.00043647448],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000057306483,0.000761666,0.0042520864,0.00026928514,0.00004215221,0.000043027587,0.000114530725,0.00018283831,0.00006735641],"category_scores_gemma":[0.00001683474,0.00035741366,0.0012726535,0.00027184165,0.00004956459,0.00006403744,0.000037638252,0.00020982337,0.00006180077],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000119460325,0.003036515,0.0030752665,0.010365243,0.0044436143,0.00900464,0.000010039973,2.137955e-7,8.027228e-9,0.00016413876,0.00031928704,0.96946156],"study_design_scores_gemma":[0.005484216,0.0061067725,0.005650154,0.07412094,0.018504843,0.009620517,0.000021502494,3.4943264e-7,6.00137e-7,0.000063137355,0.88010603,0.00032095937],"about_ca_topic_score_codex":0.0000056271715,"about_ca_topic_score_gemma":9.0223773e-7,"teacher_disagreement_score":0.9691406,"about_ca_system_score_codex":0.0010265803,"about_ca_system_score_gemma":0.00024410918,"threshold_uncertainty_score":0.99988776},"labels":[],"label_agreement":null},{"id":"W3094082904","doi":"10.1080/09546634.2020.1840502","title":"Antihistamines-refractory chronic pruritus in psoriatic patients undergoing biologics: aprepitant vs antihistamine double dosage, a real-world data","year":2020,"lang":"en","type":"article","venue":"Journal of Dermatological Treatment","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"York University","funders":"","keywords":"Medicine; Aprepitant; Psoriasis; Antihistamine; Refractory (planetary science); Psoriatic arthritis; Internal medicine; Dermatology; Apremilast; Gastroenterology; Anesthesia; Pharmacology; Chemotherapy; Antiemetic","score_opus":0.06610967567425224,"score_gpt":0.293384985865162,"score_spread":0.22727531019090974,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3094082904","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.988547,0.008279762,0.000040182385,0.0011875543,0.00065453723,0.00052964664,0.0001809358,0.00006137195,0.00051901187],"genre_scores_gemma":[0.99043405,0.00815488,0.00039134518,0.00014998726,0.00013131234,0.000017437178,0.00050165167,0.000024038312,0.00019531777],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99687624,0.00046436203,0.0013526261,0.00057766895,0.00013005476,0.0005990413],"domain_scores_gemma":[0.9976907,0.0005308488,0.0010134769,0.0005300091,0.00010448382,0.00013048829],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00024858996,0.00048328773,0.0012924833,0.0002643741,0.00014867536,0.00003655949,0.0006554142,0.00024352461,0.0001446037],"category_scores_gemma":[0.00017169137,0.00030811375,0.0002605307,0.0004665668,0.00019067776,0.0002982662,0.00021914806,0.0003056535,0.00012888735],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005990606,0.00650834,0.91537213,0.00017619591,0.002277312,0.002535156,0.00068592385,0.00005333754,0.006177355,0.00034299033,0.0038475802,0.056033064],"study_design_scores_gemma":[0.0869794,0.021259634,0.73716027,0.00059053145,0.0020360372,0.00073937303,0.00046588163,0.00014635542,0.022938084,0.00026647592,0.12575024,0.0016677104],"about_ca_topic_score_codex":0.00007518378,"about_ca_topic_score_gemma":0.0003680848,"teacher_disagreement_score":0.17821187,"about_ca_system_score_codex":0.00058902276,"about_ca_system_score_gemma":0.0002719269,"threshold_uncertainty_score":0.9999371},"labels":[],"label_agreement":null},{"id":"W3109355046","doi":"10.1080/09546634.2020.1839008","title":"Baricitinib improves symptoms in patients with moderate-to-severe atopic dermatitis and inadequate response to topical corticosteroids: patient-reported outcomes from two randomized monotherapy phase III trials","year":2020,"lang":"en","type":"article","venue":"Journal of Dermatological Treatment","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Cilag; LEO Pharma; Sanofi Genzyme; Incyte; Medac; XBiotech; Kiniksa Pharmaceuticals; Fresenius Medical Care North America; Dermira; UCB Pharma; Regeneron Pharmaceuticals; Les Laboratories Pierre Fabre; Biogen; Celgene; Samsung; Valeant Pharmaceuticals International; Sanofi; Amgen; Pfizer; Galderma; Eli Lilly and Company; GlaxoSmithKline","keywords":"Medicine; Atopic dermatitis; Dermatology; Randomized controlled trial; Corticosteroid; Surgery","score_opus":0.032958681508670706,"score_gpt":0.3156504988386487,"score_spread":0.282691817329978,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3109355046","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9829371,0.00044755102,0.00056434283,0.013975187,0.00008075071,0.0019116598,0.00003751785,0.000026750484,0.000019136178],"genre_scores_gemma":[0.99069226,0.00005851997,0.0011950672,0.007896775,0.000028385239,0.00008439454,0.00002069807,0.00001641748,0.000007463632],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9961609,0.0010663111,0.0017896527,0.00032023594,0.00036727393,0.00029557527],"domain_scores_gemma":[0.9967325,0.0016194994,0.0006126948,0.00018748088,0.00015271292,0.00069511967],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022546118,0.00034859168,0.0026860875,0.00017062132,0.00006345812,0.00005183077,0.000090897025,0.00013028274,0.000073532174],"category_scores_gemma":[0.0015768465,0.00018677015,0.00029724403,0.00016356187,0.0000921848,0.00013519681,0.000039738996,0.00018296672,0.000006386853],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4866738,0.0016249623,0.48330158,0.000015346786,0.0014403664,0.0031195297,0.0015070615,0.000039644263,0.000087857385,0.000009587507,0.0001692298,0.022011025],"study_design_scores_gemma":[0.521992,0.0037863557,0.47130457,0.00013644,0.0007031434,0.00029178362,0.00011852334,0.00023473753,0.0008488616,0.00015544094,0.00020602488,0.00022208966],"about_ca_topic_score_codex":0.000019876035,"about_ca_topic_score_gemma":0.0000032543217,"teacher_disagreement_score":0.035318233,"about_ca_system_score_codex":0.00010260938,"about_ca_system_score_gemma":0.0001251752,"threshold_uncertainty_score":0.76162654},"labels":[],"label_agreement":null},{"id":"W3157474078","doi":"10.1080/09546634.2021.1927949","title":"Efficacy of non-surgical monotherapies for hidradenitis suppurativa: a systematic review and network meta-analyses of randomized trials","year":2021,"lang":"en","type":"review","venue":"Journal of Dermatological Treatment","topic":"Hidradenitis Suppurativa and Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; Mediprobe Research (Canada); Women's College Hospital; University of Toronto","funders":"","keywords":"Medicine; Placebo; Hidradenitis suppurativa; Anakinra; Infliximab; Adalimumab; Randomized controlled trial; Flucloxacillin; Internal medicine; Surgery; Meta-analysis; Disease","score_opus":0.3801484934765829,"score_gpt":0.49827773216139926,"score_spread":0.11812923868481634,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3157474078","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000012970154,0.98812693,0.0001784296,0.0012946662,0.00007718548,0.010077942,0.00017256025,0.000008018078,0.000051282714],"genre_scores_gemma":[0.0020890674,0.99255985,0.0037853112,0.000010585839,0.000109894165,0.0011336092,0.000115496645,0.00004454459,0.00015161172],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9847034,0.005705525,0.008301144,0.00037723966,0.0005853948,0.00032726882],"domain_scores_gemma":[0.970799,0.019646883,0.0082856305,0.00045793294,0.00054051855,0.00027002045],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":["metaepi_broad"],"category_scores_codex":[0.00048193394,0.00092822325,0.06126249,0.0002614569,0.00006638506,0.000032529013,0.00018695147,0.00041049867,0.00025071183],"category_scores_gemma":[0.0040744185,0.00037243983,0.016060218,0.0003900366,0.00027675147,0.000085561594,0.000040325587,0.000250519,0.0000022081326],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004645298,0.0021312751,0.0000051878974,0.6505743,0.30956903,0.021262126,0.000103758415,3.4555907e-7,0.0000010633494,0.00016165916,0.00031625622,0.011229699],"study_design_scores_gemma":[0.059820596,0.0011275543,3.6072228e-7,0.20641856,0.58725893,0.14037402,0.000021335392,0.000001890072,0.000032892334,0.000050832045,0.004684991,0.00020801394],"about_ca_topic_score_codex":0.0000033711106,"about_ca_topic_score_gemma":2.7098108e-7,"teacher_disagreement_score":0.44415575,"about_ca_system_score_codex":0.00013474515,"about_ca_system_score_gemma":0.00043145838,"threshold_uncertainty_score":0.99987274},"labels":[],"label_agreement":null},{"id":"W3159131528","doi":"10.1080/09546634.2021.1902925","title":"Efficacy, tolerability, patient usability, and satisfaction with a 2 mL pre-filled syringe containing secukinumab 300 mg in patients with moderate to severe plaque psoriasis: results from the phase 3 randomized, double-blind, placebo-controlled ALLURE study","year":2021,"lang":"en","type":"article","venue":"Journal of Dermatological Treatment","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; SKiN Health; University of British Columbia","funders":"","keywords":"Secukinumab; Medicine; Tolerability; Placebo; Psoriasis Area and Severity Index; Psoriasis; Bioequivalence; Randomized controlled trial; Clinical endpoint; Adverse effect; Internal medicine; Pharmacokinetics; Dermatology; Psoriatic arthritis; Pathology","score_opus":0.023625956233543143,"score_gpt":0.2691566812626643,"score_spread":0.24553072502912116,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3159131528","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992868,0.00071267545,0.000051179093,0.0008486011,0.0002020644,0.0051090247,0.00014072248,0.000025882837,0.000041862375],"genre_scores_gemma":[0.9989207,0.00007190505,0.0002749345,0.0000828172,0.000028454982,0.00046921684,0.000114096845,0.000019415787,0.000018484468],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99518913,0.0022608053,0.001291594,0.00062090636,0.00022878154,0.0004087642],"domain_scores_gemma":[0.99585193,0.0025357623,0.000765473,0.000419679,0.0003107374,0.00011640848],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006083559,0.0005290916,0.0021027161,0.000111424786,0.0002818576,0.00009964107,0.00015061526,0.00024165661,0.00006138479],"category_scores_gemma":[0.00027049318,0.0002447425,0.0002585384,0.00021277301,0.00013699982,0.00016997929,0.000093407085,0.0003425778,0.000006207189],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8269011,0.0062041995,0.14883395,0.0000045365387,0.0037908552,0.00035108125,0.0057599046,0.0007568474,0.000036690923,0.000007868303,0.000013497049,0.007339481],"study_design_scores_gemma":[0.89652556,0.0075275186,0.09103356,0.00014719996,0.0015267758,0.00029247426,0.0017704759,0.000028679413,0.00079601543,0.00003171839,0.000037533155,0.00028247404],"about_ca_topic_score_codex":0.00028644683,"about_ca_topic_score_gemma":0.0014419312,"teacher_disagreement_score":0.06962448,"about_ca_system_score_codex":0.00031047701,"about_ca_system_score_gemma":0.00018914611,"threshold_uncertainty_score":0.9980309},"labels":[],"label_agreement":null},{"id":"W3164549179","doi":"10.1080/09546634.2021.1937480","title":"Data mining for detecting signals of adverse drug reaction of doxycycline using the Korea adverse event reporting system database","year":2021,"lang":"en","type":"article","venue":"Journal of Dermatological Treatment","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Adverse effect; Pharmacovigilance; Malaise; Adverse drug reaction; Doxycycline; Dermatology; Adverse Event Reporting System; Hyperpigmentation; Internal medicine; Paronychia; Database; Surgery; Drug; Antibiotics; Pharmacology","score_opus":0.3452900453759856,"score_gpt":0.4972952069914539,"score_spread":0.1520051616154683,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3164549179","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952484,0.0010212942,0.0014441451,0.00038021614,0.00084343576,0.0003868119,0.00048197593,0.000019036825,0.00017469686],"genre_scores_gemma":[0.99508923,0.00045963316,0.0039539295,0.00011754749,0.00022818141,0.000013085822,0.00008719156,0.00001491748,0.000036270867],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99633676,0.00053408457,0.0022891904,0.00027506598,0.00025988228,0.00030501935],"domain_scores_gemma":[0.99262816,0.0015711545,0.004816358,0.00041405263,0.00041202622,0.00015825876],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018159553,0.00022751484,0.0007732308,0.00010768473,0.00027442886,0.0000048905204,0.00030092584,0.00013690186,0.000042587966],"category_scores_gemma":[0.0009839827,0.00014633765,0.00042009188,0.00025041998,0.00011417956,0.00032318378,0.00013836939,0.00037589017,0.0000012951524],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014026093,0.0021365974,0.030232478,0.00065786357,0.0024349059,0.0023077368,0.0008858829,0.018593386,0.9346085,0.000084852654,0.00062112923,0.006034044],"study_design_scores_gemma":[0.005821389,0.00022697849,0.0012132429,0.00069968385,0.00355809,0.0076927342,0.016228652,0.043048408,0.9084692,0.00003170109,0.012722984,0.00028693373],"about_ca_topic_score_codex":0.000013532293,"about_ca_topic_score_gemma":0.0000087599865,"teacher_disagreement_score":0.029019235,"about_ca_system_score_codex":0.00021435668,"about_ca_system_score_gemma":0.0003305562,"threshold_uncertainty_score":0.59674764},"labels":[],"label_agreement":null},{"id":"W3174298125","doi":"10.1080/09546634.2021.1945527","title":"Minoxidil: a comprehensive review","year":2021,"lang":"en","type":"review","venue":"Journal of Dermatological Treatment","topic":"Hair Growth and Disorders","field":"Medicine","cited_by":211,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mediprobe Research (Canada); University of Toronto","funders":"","keywords":"Medicine; Minoxidil; Dermatology","score_opus":0.1795974074302688,"score_gpt":0.4393575185586624,"score_spread":0.2597601111283936,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3174298125","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000012614073,0.9971055,0.000009612615,0.0008130818,0.0001721417,0.000747801,0.000012715882,0.000015668358,0.0011109052],"genre_scores_gemma":[0.000004362777,0.9975002,0.0008479921,0.0012673476,0.00012765266,0.00003253987,0.00007019969,0.000024791598,0.00012495424],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973514,0.0003217111,0.0014356554,0.0002358076,0.00037150324,0.00028390234],"domain_scores_gemma":[0.9977893,0.00031114765,0.0008833928,0.00030619628,0.00028431133,0.00042565327],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000077372744,0.0004883747,0.0058710612,0.00014506499,0.000037588696,0.000015468697,0.00013144194,0.00031005638,0.0003533278],"category_scores_gemma":[0.00019276635,0.00024232602,0.0027917898,0.0002997162,0.00006556557,0.00003495895,0.00003754715,0.0004009586,0.00010357844],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000015869695,0.0008762258,0.0000361737,0.05393401,0.001462168,0.015158939,0.00000975862,4.201079e-8,8.456405e-8,0.00004248354,0.014469291,0.91399497],"study_design_scores_gemma":[0.000891862,0.00059551076,0.000007282411,0.09124868,0.0064628767,0.047615014,0.00001839907,1.0665797e-7,9.2784524e-7,0.000007981566,0.85299623,0.0001551345],"about_ca_topic_score_codex":8.429925e-7,"about_ca_topic_score_gemma":1.6006202e-7,"teacher_disagreement_score":0.9138398,"about_ca_system_score_codex":0.00025096527,"about_ca_system_score_gemma":0.0008434518,"threshold_uncertainty_score":0.9881768},"labels":[],"label_agreement":null},{"id":"W3187307731","doi":"10.1080/09546634.2021.1959501","title":"Efficacy and safety of proactive treatment with twice-weekly topical Cal/BD foam in patients with plaque psoriasis undergoing HPA-axis testing: a PSO-LONG subgroup analysis","year":2021,"lang":"en","type":"article","venue":"Journal of Dermatological Treatment","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Western University; Probity Medical Research","funders":"LEO Pharma","keywords":"Medicine; Psoriasis; Clinical endpoint; Hazard ratio; Internal medicine; Adverse effect; Gastroenterology; Dermatology; Randomized controlled trial; Confidence interval","score_opus":0.023649579152604096,"score_gpt":0.2408794334713459,"score_spread":0.2172298543187418,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3187307731","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968239,0.0018685759,0.00020686469,0.000324675,0.00007020214,0.00046121722,0.00004014491,0.000017219418,0.00018717718],"genre_scores_gemma":[0.99711096,0.0005022083,0.002126484,0.00002251234,0.000019272182,0.000032327214,0.00008556945,0.000016165226,0.00008450388],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976946,0.00050711527,0.00079583685,0.00044324592,0.0001466415,0.00041256932],"domain_scores_gemma":[0.9975646,0.0012286308,0.00057445274,0.00026921404,0.00025549572,0.000107600856],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009739659,0.00043934057,0.0013829983,0.00028513433,0.00014307814,0.000024419898,0.00011266534,0.00027393855,0.0000659251],"category_scores_gemma":[0.00009909239,0.00024100438,0.00026855836,0.00069926895,0.00017813753,0.00013560196,0.000041340012,0.00017717248,0.000003587891],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007728624,0.0055268523,0.94498897,0.000017409855,0.011069398,0.0009738113,0.0005694187,0.00011426975,0.00024353986,0.0000498386,0.0000052039536,0.028712638],"study_design_scores_gemma":[0.02623902,0.011081551,0.9470949,0.000120206874,0.004604657,0.0006428228,0.0004123465,0.000007515305,0.00937751,0.00002592779,0.0001271626,0.00026635182],"about_ca_topic_score_codex":0.00007109541,"about_ca_topic_score_gemma":0.00033403453,"teacher_disagreement_score":0.028446287,"about_ca_system_score_codex":0.00044012518,"about_ca_system_score_gemma":0.00026982446,"threshold_uncertainty_score":0.9827874},"labels":[],"label_agreement":null},{"id":"W3190122872","doi":"10.1080/09546634.2021.1959504","title":"Efficacy of guselkumab versus secukinumab in subpopulations of patients with moderate-to-severe plaque psoriasis: results from the ECLIPSE study","year":2021,"lang":"en","type":"article","venue":"Journal of Dermatological Treatment","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Guenther Dermatology Research Centre; Probity Medical Research; Dalhousie University","funders":"","keywords":"Secukinumab; Medicine; Plaque psoriasis; Dermatology; Psoriasis; Psoriatic arthritis","score_opus":0.03732038913152342,"score_gpt":0.2685031290800881,"score_spread":0.2311827399485647,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3190122872","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976771,0.00062690565,0.0000066528187,0.0003178172,0.00040193307,0.0004647186,0.0003932542,0.00000667103,0.00010494431],"genre_scores_gemma":[0.99933845,0.00008984543,0.0002808744,0.000018284603,0.00003532816,0.00001700595,0.00018343017,0.0000097468255,0.000027019925],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978351,0.00061064254,0.00095254806,0.00024942285,0.00013237771,0.00021990402],"domain_scores_gemma":[0.99765724,0.0011167892,0.000575623,0.0003528489,0.00025485925,0.00004265056],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001267418,0.00024007929,0.00077190803,0.00009785557,0.000093882605,0.000010884246,0.00020295115,0.00016060646,0.0000875786],"category_scores_gemma":[0.00022386647,0.00012529324,0.00019376638,0.00028793784,0.00006216804,0.00007285207,0.00005230468,0.00014854709,0.000013279378],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09192083,0.021554427,0.8593623,0.000008788436,0.0055437665,0.0006146199,0.0075751687,0.0026687463,0.0003917496,0.00011000152,0.00046844035,0.009781131],"study_design_scores_gemma":[0.070454255,0.0033231236,0.91458505,0.00008776645,0.00081461895,0.000054785232,0.0016529581,0.0000023707753,0.008450285,0.0000745603,0.00034262473,0.00015759305],"about_ca_topic_score_codex":0.00009019641,"about_ca_topic_score_gemma":0.00033889074,"teacher_disagreement_score":0.055222727,"about_ca_system_score_codex":0.00012705858,"about_ca_system_score_gemma":0.00014349709,"threshold_uncertainty_score":0.51093096},"labels":[],"label_agreement":null},{"id":"W3193000512","doi":"10.1080/09546634.2021.1967269","title":"Isotretinoin for acne vulgaris – an update on adverse effects and laboratory monitoring","year":2021,"lang":"en","type":"review","venue":"Journal of Dermatological Treatment","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health","funders":"","keywords":"Isotretinoin; Medicine; Adverse effect; Acne; Dermatology; Mucocutaneous zone; Confusion; Intensive care medicine; Disease; Internal medicine","score_opus":0.06410575999496682,"score_gpt":0.39910592866676253,"score_spread":0.3350001686717957,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3193000512","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0120407175,0.9862511,0.000016470925,0.00016220764,0.0004076487,0.0010037601,0.000047463345,0.000020414554,0.00005018206],"genre_scores_gemma":[0.0010840269,0.9963223,0.0017216335,0.000109120774,0.00045569538,0.00009611398,0.00007641603,0.000042220137,0.000092517024],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981314,0.00027915952,0.0006890013,0.00034607717,0.000236299,0.0003180775],"domain_scores_gemma":[0.9980506,0.0005362834,0.000581752,0.000264745,0.00013733494,0.00042933298],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00014689229,0.0005500101,0.0030143082,0.00016522559,0.00013419951,0.000033387758,0.0000784176,0.00043002842,0.000015920574],"category_scores_gemma":[0.00010676343,0.00027382956,0.0008099526,0.00013476389,0.000049816466,0.000085419495,0.000030244306,0.00030209892,0.000010808409],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026662095,0.0025774282,0.0013368052,0.008302595,0.0029911946,0.011931196,0.00006983352,9.592e-7,0.0000055697656,0.00006807446,0.00090201,0.9715477],"study_design_scores_gemma":[0.005096609,0.008531831,0.00033740007,0.020058002,0.008184936,0.004065705,0.00005414542,0.0000032159776,0.0002957905,0.000014891033,0.9530214,0.00033605105],"about_ca_topic_score_codex":9.3283626e-7,"about_ca_topic_score_gemma":1.4974161e-7,"teacher_disagreement_score":0.9712117,"about_ca_system_score_codex":0.0002828417,"about_ca_system_score_gemma":0.00026205662,"threshold_uncertainty_score":0.9999714},"labels":[],"label_agreement":null},{"id":"W4220705068","doi":"10.1080/09546634.2022.2049589","title":"Time to codify a challenge in communication","year":2022,"lang":"en","type":"article","venue":"Journal of Dermatological Treatment","topic":"Patient-Provider Communication in Healthcare","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Medical care; Medical practice; Medical literature; Intensive care medicine; Resistance (ecology); MEDLINE; Immunization; Health care; Family medicine; Immunology; Pathology","score_opus":0.2766925474117619,"score_gpt":0.4399309135712461,"score_spread":0.16323836615948417,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220705068","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.82858723,0.012432615,0.00001480793,0.14480104,0.00033670838,0.0022185629,0.000059356717,0.00006932186,0.011480329],"genre_scores_gemma":[0.9952726,0.000384453,0.0015973237,0.0018862823,0.000023736999,0.000498553,0.000016401054,0.000011974375,0.00030872345],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9951738,0.00296811,0.0010986293,0.00012361279,0.00032874808,0.0003070589],"domain_scores_gemma":[0.9974152,0.0010601362,0.0006273241,0.0005470143,0.0001595712,0.00019074722],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00036607092,0.00012684867,0.00044457085,0.00022772726,0.00066362205,0.000004232824,0.0005495583,0.00008672962,0.0016630803],"category_scores_gemma":[0.00019788208,0.00009582217,0.00009969859,0.00028698717,0.000035310597,0.00007930227,0.00040217844,0.00077261624,0.00036597846],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004408805,0.015558689,0.6269607,0.00042870463,0.0005319895,0.0013455459,0.20859045,0.0049669375,0.0002930539,0.010547238,0.08265367,0.043714214],"study_design_scores_gemma":[0.014430685,0.0070636086,0.11391715,0.0006520532,0.00009777882,0.00064848195,0.071938105,0.0014758761,0.00005145923,0.006297704,0.7827381,0.0006890268],"about_ca_topic_score_codex":0.000046223813,"about_ca_topic_score_gemma":0.000029027327,"teacher_disagreement_score":0.7000844,"about_ca_system_score_codex":0.0014959398,"about_ca_system_score_gemma":0.00027779778,"threshold_uncertainty_score":0.9992495},"labels":[],"label_agreement":null},{"id":"W4281294257","doi":"10.1080/09546634.2022.2067814","title":"Preliminary efficacy and safety analysis: 12-month results in 83 patients using a novel approach of widefield radiation therapy for extensive skin field cancerization with or without keratinocyte cancers","year":2022,"lang":"en","type":"article","venue":"Journal of Dermatological Treatment","topic":"Nonmelanoma Skin Cancer Studies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"","keywords":"Medicine; Cosmesis; Field cancerization; Dermatology; Skin cancer; Radiation therapy; Clinical trial; Cancer; Surgery; Internal medicine","score_opus":0.04405874643816851,"score_gpt":0.3103970111432307,"score_spread":0.26633826470506217,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281294257","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940132,0.0013960878,0.0028518909,0.00045636858,0.00004887651,0.0010862042,0.00006556612,0.000003785703,0.00007804791],"genre_scores_gemma":[0.98973006,0.00084711687,0.0090655275,0.00018822795,0.00002914588,0.000083254636,0.00003725687,0.000008807286,0.000010620121],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998718,0.00007866474,0.0005928916,0.00020236065,0.0002625861,0.00014550099],"domain_scores_gemma":[0.99875003,0.0003061979,0.00063428347,0.000114070535,0.00013906507,0.000056338784],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011149273,0.00015653913,0.0007324287,0.00018355367,0.00010931525,0.0000072738303,0.000046794823,0.00004967453,0.000007934556],"category_scores_gemma":[0.00008754777,0.000090991205,0.00009983818,0.00029961558,0.000038972372,0.00006134702,0.000023408964,0.00011163765,9.673335e-9],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.120086454,0.0018841475,0.8239797,0.000066299464,0.0025153728,0.00007748919,0.0038648047,0.027536195,0.00008359092,0.000009859471,0.000061576815,0.019834511],"study_design_scores_gemma":[0.04474847,0.02281597,0.9160695,0.00013003644,0.0013319253,0.0003467944,0.0013556172,0.011151007,0.00147664,0.000006533526,0.00038700056,0.00018049966],"about_ca_topic_score_codex":0.00018297326,"about_ca_topic_score_gemma":0.00007373297,"teacher_disagreement_score":0.09208981,"about_ca_system_score_codex":0.00057631073,"about_ca_system_score_gemma":0.00021968495,"threshold_uncertainty_score":0.37105137},"labels":[],"label_agreement":null},{"id":"W4287219390","doi":"10.1080/09546634.2022.2095330","title":"Matching-adjusted indirect comparison of efficacy outcomes in trials of calcipotriol plus betamethasone dipropionate foam and cream formulations for the treatment of plaque psoriasis","year":2022,"lang":"en","type":"article","venue":"Journal of Dermatological Treatment","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"LEO Pharma","keywords":"Medicine; Betamethasone dipropionate; Calcipotriol; Plaque psoriasis; Dermatology; Betamethasone; Psoriasis; Randomized controlled trial; Surgery; Internal medicine","score_opus":0.12532798555622987,"score_gpt":0.36141883211665476,"score_spread":0.2360908465604249,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4287219390","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9843289,0.0129341185,0.00017171114,0.0004477465,0.00031214484,0.0012420636,0.000539623,0.000007913112,0.000015726913],"genre_scores_gemma":[0.99746984,0.001467615,0.00070170296,0.000008189334,0.000014299837,0.00018415283,0.000072155635,0.000011403943,0.000070638496],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967072,0.00091171847,0.0018385655,0.00018559098,0.00012005823,0.00023683789],"domain_scores_gemma":[0.9915473,0.0063245436,0.0017883842,0.00020812893,0.00009653334,0.000035108045],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005831233,0.00027684387,0.0023927612,0.00029145592,0.00019208834,0.000005364113,0.00017859666,0.0001637016,0.00010623668],"category_scores_gemma":[0.00019322034,0.00014145058,0.0007493566,0.00020521546,0.00013899479,0.00004924674,0.00004225377,0.00011165884,7.000134e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023234831,0.04404607,0.6190874,0.00017943826,0.019407373,0.00009341636,0.02423804,0.006760005,0.023081783,0.0022533475,0.00020061393,0.23741768],"study_design_scores_gemma":[0.08892735,0.029571882,0.5845673,0.00013864908,0.00798622,0.0004990439,0.0063930396,0.0001687361,0.27448684,0.0018223862,0.004938331,0.00050020573],"about_ca_topic_score_codex":0.00013673428,"about_ca_topic_score_gemma":0.000047616726,"teacher_disagreement_score":0.25140503,"about_ca_system_score_codex":0.00024111247,"about_ca_system_score_gemma":0.00011572139,"threshold_uncertainty_score":0.57681876},"labels":[],"label_agreement":null},{"id":"W4289711861","doi":"10.1080/09546634.2022.2109567","title":"Comparison of oral minoxidil, finasteride, and dutasteride for treating androgenetic alopecia","year":2022,"lang":"en","type":"review","venue":"Journal of Dermatological Treatment","topic":"Hair Growth and Disorders","field":"Medicine","cited_by":96,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mediprobe Research (Canada); University of Toronto","funders":"","keywords":"Finasteride; Minoxidil; Dutasteride; Medicine; Hair loss; Male-pattern baldness; Urology; 5 Alpha-Reductase Inhibitor; Dermatology; Dihydrotestosterone; Internal medicine; Pharmacology; Scalp; Androgen; Prostate","score_opus":0.21519005073356512,"score_gpt":0.4474377420550728,"score_spread":0.2322476913215077,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4289711861","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.016145235,0.98240125,0.00005996538,0.000082939834,0.00010125154,0.00087937526,0.00007333144,0.0000075199227,0.00024914683],"genre_scores_gemma":[0.0048239706,0.9913586,0.003493515,0.00003895022,0.00004870258,0.00007519776,0.000075387914,0.000028264703,0.00005744139],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99764484,0.00016091156,0.0014642279,0.00021957369,0.00025117738,0.0002592408],"domain_scores_gemma":[0.99797887,0.0004523068,0.0011192635,0.00016142477,0.000058734644,0.00022938714],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013172886,0.00038087947,0.0036322498,0.00020775836,0.000076981,0.000016809745,0.00010386709,0.00017374201,0.00013888143],"category_scores_gemma":[0.0001359323,0.00022264161,0.0008766047,0.0001416567,0.00008237584,0.00003466582,0.000052752544,0.0001871203,0.0000020329894],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031529317,0.0010376457,0.00495724,0.0062989015,0.00078431464,0.00044925016,0.00012533975,0.0000019216038,0.0000028060815,0.000012312314,0.00037754304,0.9856374],"study_design_scores_gemma":[0.0033107924,0.005588402,0.00019982134,0.0021952207,0.0038173667,0.00715969,0.00027829668,0.000023058039,0.000043148342,0.000022357453,0.97716725,0.00019460292],"about_ca_topic_score_codex":0.0000025501424,"about_ca_topic_score_gemma":0.000002286919,"teacher_disagreement_score":0.9854428,"about_ca_system_score_codex":0.00013966692,"about_ca_system_score_gemma":0.00025922296,"threshold_uncertainty_score":0.9079061},"labels":[],"label_agreement":null},{"id":"W4367048315","doi":"10.1080/09546634.2023.2193663","title":"The clinical relevance of dupilumab serum concentration in patients with atopic dermatitis: a two-center prospective cohort study","year":2023,"lang":"en","type":"article","venue":"Journal of Dermatological Treatment","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"LEO Pharma; Galderma; Sanofi Genzyme; ZonMw; Department of Health and Social Care; National Institute for Health and Care Research; Sanofi; King's College London; Pfizer","keywords":"Dupilumab; Atopic dermatitis; Medicine; Eczema Area and Severity Index; Discontinuation; Adverse effect; Dermatology; Single Center; Internal medicine; Cohort; Clinical trial; Gastroenterology","score_opus":0.021059547196795553,"score_gpt":0.328815252455005,"score_spread":0.30775570525820944,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4367048315","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972684,0.00024908947,0.000005466957,0.00091471244,0.00013986712,0.0011655889,0.000007982245,0.000017113967,0.00023178056],"genre_scores_gemma":[0.9993943,0.0003210303,0.000058403577,0.00012019354,0.000023288567,0.00004169143,0.000008024757,0.000007088458,0.000025977879],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99803627,0.00031975252,0.0009059672,0.00015962656,0.00036309505,0.00021529429],"domain_scores_gemma":[0.9986049,0.00043041687,0.00044336676,0.00018740355,0.00022595144,0.00010799136],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022623224,0.00014626746,0.0006458889,0.000054797278,0.0000787855,0.00001261489,0.00009244502,0.0000675601,0.000013308144],"category_scores_gemma":[0.00023573237,0.0000696622,0.00014461367,0.00022127813,0.00018217269,0.00009444242,0.000023569555,0.00018546617,0.000012495745],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00069752004,0.0039268658,0.9919384,0.000014410203,0.00046504688,0.0010315878,0.00015859865,0.000008881384,2.2324478e-7,0.00003769829,0.00048710496,0.0012336527],"study_design_scores_gemma":[0.016343765,0.0018304646,0.98055947,0.00010725706,0.00020465818,0.00025046646,0.0002564463,0.00003664374,0.000042873064,0.00015848633,0.00014803222,0.00006145553],"about_ca_topic_score_codex":0.000001960647,"about_ca_topic_score_gemma":0.000014932766,"teacher_disagreement_score":0.015646243,"about_ca_system_score_codex":0.00011019679,"about_ca_system_score_gemma":0.000119905795,"threshold_uncertainty_score":0.28407422},"labels":[],"label_agreement":null},{"id":"W4381469293","doi":"10.1080/09546634.2023.2220446","title":"Dermal sensitization, safety, and tolerability of triple-combination clindamycin phosphate 1.2%/benzoyl peroxide 3.1%/adapalene 0.15% gel from three clinical trials","year":2023,"lang":"en","type":"article","venue":"Journal of Dermatological Treatment","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Bausch Health; Ortho Dermatologics","keywords":"Adapalene; Tolerability; Benzoyl peroxide; Medicine; Dermatology; Acne; Clindamycin; Sensitization; Adverse effect; Internal medicine; Pharmacology; Antibiotics; Immunology","score_opus":0.13105051433665066,"score_gpt":0.40756252014543665,"score_spread":0.276512005808786,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4381469293","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9906827,0.0018102675,0.0004366704,0.005799152,0.00040090678,0.000656536,0.00006111139,0.00002876883,0.0001238445],"genre_scores_gemma":[0.9938942,0.0045580314,0.00090027513,0.00020119874,0.0001899899,0.0000058672895,0.000087919514,0.000015801734,0.00014668015],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99595743,0.0007551847,0.0023364902,0.0002965483,0.0003891652,0.00026516244],"domain_scores_gemma":[0.99586314,0.0022161852,0.0011043373,0.00023115474,0.00027009132,0.00031509297],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017653897,0.00027906522,0.0020751122,0.00013785783,0.00012081762,0.00002304852,0.000069177404,0.00029515455,0.0001354832],"category_scores_gemma":[0.0013484943,0.00015437177,0.0006191526,0.00023966552,0.00014886512,0.00012677161,0.000047025893,0.0002041643,0.000024851039],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0041558133,0.0024403608,0.95675355,0.00006750901,0.0013790157,0.001115507,0.0002109231,0.000045992314,0.0007907719,0.00016791375,0.0009789235,0.031893708],"study_design_scores_gemma":[0.020640446,0.0032474261,0.96310294,0.00020533572,0.0013281355,0.0005459665,0.00011872373,0.0013863186,0.0066770357,0.0018887204,0.00069803506,0.00016090082],"about_ca_topic_score_codex":0.000025737962,"about_ca_topic_score_gemma":0.000013477676,"teacher_disagreement_score":0.03173281,"about_ca_system_score_codex":0.000111932364,"about_ca_system_score_gemma":0.00014890992,"threshold_uncertainty_score":0.62950975},"labels":[],"label_agreement":null},{"id":"W4385691149","doi":"10.1080/09546634.2023.2245084","title":"Systematic review of mesotherapy: a novel avenue for the treatment of hair loss","year":2023,"lang":"en","type":"review","venue":"Journal of Dermatological Treatment","topic":"Hair Growth and Disorders","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mediprobe Research (Canada); University of Toronto","funders":"","keywords":"Medicine; Minoxidil; Hair loss; Dermatology; Adverse effect; Hair growth; Clinical trial; Dutasteride; Surgery; Pharmacology; Internal medicine; Physiology","score_opus":0.13334366607385167,"score_gpt":0.4110685831032732,"score_spread":0.27772491702942154,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385691149","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000025049383,0.9939218,0.00016532863,0.0005713115,0.00013651479,0.0049780724,0.00014906946,0.000011757444,0.000041074727],"genre_scores_gemma":[0.000046055047,0.9986417,0.00032239014,0.00011823791,0.00007620189,0.00054379593,0.000027664533,0.000040230898,0.0001836712],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99649256,0.00016300738,0.002508532,0.00018299252,0.0004040918,0.00024883848],"domain_scores_gemma":[0.9950258,0.0015877902,0.002541254,0.0004553647,0.00023317964,0.00015659253],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003307318,0.00046309142,0.0067322096,0.00017029035,0.00004363792,0.000006974808,0.00021775736,0.00022222655,0.000023473678],"category_scores_gemma":[0.00032095658,0.00017614284,0.0034761105,0.0003057954,0.00011559881,0.000021554311,0.00001119294,0.00010902895,0.000010603529],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009347262,0.0021927913,0.000020707033,0.9590363,0.0064866976,0.00022436604,0.00012059445,5.062341e-7,2.742735e-7,0.00010589046,0.000269742,0.03144869],"study_design_scores_gemma":[0.0035165958,0.0045950036,0.000007866013,0.7208501,0.027346803,0.003310808,0.00007826861,0.0000057064044,0.0000112054195,0.000053808177,0.24006209,0.00016176455],"about_ca_topic_score_codex":0.0000046538057,"about_ca_topic_score_gemma":0.0000013501336,"teacher_disagreement_score":0.23979235,"about_ca_system_score_codex":0.00029538517,"about_ca_system_score_gemma":0.00047644685,"threshold_uncertainty_score":0.7182897},"labels":[],"label_agreement":null},{"id":"W4385798576","doi":"10.1080/09546634.2023.2245081","title":"Fixed-combination halobetasol propionate and tazarotene topical lotion decreases TNF-α and IL-17A levels in psoriatic lesions","year":2023,"lang":"en","type":"article","venue":"Journal of Dermatological Treatment","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Bausch Health; Ortho Dermatologics","keywords":"Medicine; Lotion; Tazarotene; Dermatology; Psoriasis; Clobetasol propionate; Pharmacology","score_opus":0.04533301504517874,"score_gpt":0.27711150266847906,"score_spread":0.23177848762330033,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385798576","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946926,0.0030009544,0.00003471303,0.0016525073,0.00027200542,0.00024854465,0.000023645867,0.000028914328,0.00004610604],"genre_scores_gemma":[0.9971383,0.0022999428,0.0002353832,0.000035392175,0.000024379824,0.000028562763,0.000039242113,0.0000066587563,0.00019211655],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99879915,0.0002968257,0.00042955356,0.0001850879,0.000059058148,0.00023034964],"domain_scores_gemma":[0.9992807,0.0003402104,0.00018226942,0.00008732482,0.000051034367,0.000058474758],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014574353,0.00018167516,0.00043180076,0.0002034801,0.00012981446,0.000020079744,0.000062270425,0.00020377872,0.000050263978],"category_scores_gemma":[0.00013683623,0.00011309182,0.00009318499,0.00016023836,0.00008864793,0.00011741817,0.000037919184,0.000110384084,0.00003630716],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00069029676,0.0027245877,0.3359316,0.000078506,0.0009351757,0.0016893959,0.0007944479,0.000027707003,0.01650482,0.004886733,0.00052070623,0.635216],"study_design_scores_gemma":[0.0062388116,0.00109099,0.97137046,0.00009498787,0.00023189487,0.0016708955,0.0001655956,0.000040059636,0.014287028,0.0033425682,0.0013054821,0.0001612474],"about_ca_topic_score_codex":0.000013262945,"about_ca_topic_score_gemma":0.000011835094,"teacher_disagreement_score":0.63543886,"about_ca_system_score_codex":0.000080993275,"about_ca_system_score_gemma":0.00004180764,"threshold_uncertainty_score":0.46117505},"labels":[],"label_agreement":null},{"id":"W4387440451","doi":"10.1080/09546634.2023.2265658","title":"Utility of devices for onychomycosis: a review","year":2023,"lang":"en","type":"review","venue":"Journal of Dermatological Treatment","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mediprobe Research (Canada); University of Toronto","funders":"","keywords":"Medicine; Terbinafine; Nail disease; Clinical trial; Dermatology; Antifungal; Psoriasis; Pathology; Itraconazole","score_opus":0.3294596508029908,"score_gpt":0.49670262514355706,"score_spread":0.16724297434056629,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387440451","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000045469777,0.99688727,0.0000074378377,0.00024012964,0.00012652496,0.0021878087,0.0002712111,0.000020444633,0.0002137172],"genre_scores_gemma":[0.00021764188,0.9985781,0.00058107544,0.00010985464,0.000081716906,0.00018519463,0.00010545618,0.000033184264,0.00010778995],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9971346,0.0001626088,0.0018472387,0.0002504366,0.0003490149,0.00025606417],"domain_scores_gemma":[0.99672425,0.00058616966,0.0017968711,0.00033343484,0.00025710982,0.00030218877],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017811933,0.0004506235,0.005142665,0.00016668846,0.000038617378,0.000008709167,0.000160556,0.00022617032,0.00012789054],"category_scores_gemma":[0.00026753268,0.00021336977,0.0034846223,0.0002858526,0.00005502819,0.0000404687,0.000031049563,0.00014786136,0.000036894744],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000116241776,0.0020921559,0.0010964482,0.14390941,0.004743841,0.0009616521,0.000003918551,9.852927e-9,1.6365474e-8,0.000029697207,0.0038441075,0.84320253],"study_design_scores_gemma":[0.0017167031,0.0013428769,0.0007762521,0.1294376,0.026539996,0.0020234487,0.000007732371,5.5908873e-7,0.0000013232591,0.000078231176,0.83794427,0.00013099036],"about_ca_topic_score_codex":0.000002690615,"about_ca_topic_score_gemma":0.000001361294,"teacher_disagreement_score":0.8430715,"about_ca_system_score_codex":0.00013781324,"about_ca_system_score_gemma":0.0005081958,"threshold_uncertainty_score":0.8700967},"labels":[],"label_agreement":null},{"id":"W4391445529","doi":"10.1080/09546634.2024.2310633","title":"Ruxolitinib cream monotherapy demonstrates rapid improvement in the extent and signs of mild to moderate atopic dermatitis across head and neck and other anatomic regions in adolescents and adults: pooled results from 2 phase 3 studies","year":2024,"lang":"en","type":"article","venue":"Journal of Dermatological Treatment","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Innovaderm (Canada)","funders":"","keywords":"Ruxolitinib; Medicine; Atopic dermatitis; Tolerability; Janus kinase inhibitor; Eczema Area and Severity Index; Dermatology; Head and neck; Quality of life (healthcare); Internal medicine; Dupilumab; Janus kinase; Surgery; Adverse effect; Myelofibrosis","score_opus":0.04943712713521411,"score_gpt":0.3647427674632789,"score_spread":0.3153056403280648,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391445529","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9413122,0.052409638,0.000013205684,0.0055350284,0.000031730044,0.0005199739,0.00015840311,0.000007596932,0.000012229615],"genre_scores_gemma":[0.9854855,0.012976264,0.00020354267,0.0012694299,0.00001882823,0.000030092691,0.000004596131,0.000008161938,0.0000035946844],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99853826,0.0001594389,0.00069652236,0.00025432758,0.00013304583,0.00021842956],"domain_scores_gemma":[0.9992406,0.00030502284,0.00014117788,0.00011796235,0.000042258845,0.00015297512],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014717258,0.00021467185,0.0006589799,0.0001205686,0.000064572334,0.000044805696,0.00005012957,0.00009303585,0.000002563566],"category_scores_gemma":[0.00006838247,0.00011785775,0.00006455613,0.0001010496,0.00022246003,0.00008942362,0.000032772277,0.00014954133,3.3526672e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009538339,0.0063266633,0.86597955,0.00090462225,0.0017055867,0.007378292,0.030520732,0.000015202425,0.0010853743,0.00023648639,0.0009131087,0.075396016],"study_design_scores_gemma":[0.048178338,0.004674227,0.9110314,0.006628914,0.00048601208,0.003760335,0.014554043,0.0012987171,0.0047877138,0.0037085186,0.00054813235,0.00034360643],"about_ca_topic_score_codex":0.00008129973,"about_ca_topic_score_gemma":0.00012300335,"teacher_disagreement_score":0.07505241,"about_ca_system_score_codex":0.000045999794,"about_ca_system_score_gemma":0.000038505546,"threshold_uncertainty_score":0.48060995},"labels":[],"label_agreement":null},{"id":"W4396622704","doi":"10.1080/09546634.2024.2344589","title":"Rapid and sustained improvements in itch and quality of life with upadacitinib plus topical corticosteroids in adults and adolescents with atopic dermatitis: 52-week outcomes from the phase 3 AD Up study","year":2024,"lang":"en","type":"article","venue":"Journal of Dermatological Treatment","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Medicine; Atopic dermatitis; Quality of life (healthcare); Janus kinase inhibitor; Dermatology; Internal medicine; Janus kinase","score_opus":0.041961038852902206,"score_gpt":0.3281564703111934,"score_spread":0.2861954314582912,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396622704","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9904629,0.006547634,0.000018500048,0.002174465,0.000038869704,0.0007181747,0.00001940296,0.000008554847,0.000011508997],"genre_scores_gemma":[0.9988553,0.0005935515,0.000069776535,0.00042793894,0.000010062699,0.000024349727,0.000004753869,0.0000070009487,0.000007261435],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983965,0.00024838038,0.00071200985,0.00021441595,0.00024452127,0.00018412733],"domain_scores_gemma":[0.9991345,0.00031933753,0.00018098377,0.00012990605,0.00005446085,0.00018080533],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011655745,0.00020274108,0.0008150234,0.0000881982,0.000036960842,0.000031340995,0.00005513718,0.000075914264,0.000011091974],"category_scores_gemma":[0.00011176835,0.00009209239,0.000048827504,0.00009909748,0.00019157439,0.000111992114,0.00004073129,0.00020008693,2.4377468e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003007677,0.002180468,0.98383415,0.00026967635,0.00033119725,0.0026985921,0.0017795948,3.022345e-7,0.0000051900247,0.000012213156,0.000018175617,0.0058627706],"study_design_scores_gemma":[0.033467308,0.002104292,0.95732903,0.00085151894,0.00022954596,0.0005019048,0.005229024,0.00008700275,0.00003788043,0.000053183703,0.000019855346,0.000089455236],"about_ca_topic_score_codex":0.00006732766,"about_ca_topic_score_gemma":0.00017635906,"teacher_disagreement_score":0.03045963,"about_ca_system_score_codex":0.00005909455,"about_ca_system_score_gemma":0.000120223325,"threshold_uncertainty_score":0.37554187},"labels":[],"label_agreement":null},{"id":"W4396658262","doi":"10.1080/09546634.2024.2345739","title":"Patient preferences for treatment attributes in moderate-to-severe atopic dermatitis: a discrete choice experiment","year":2024,"lang":"en","type":"article","venue":"Journal of Dermatological Treatment","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Medicine; Atopic dermatitis; Logistic regression; Adverse effect; Preference; Internal medicine; Relative risk; Physical therapy; Dermatology; Confidence interval","score_opus":0.049224193754316956,"score_gpt":0.3340321053102106,"score_spread":0.28480791155589363,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396658262","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.976034,0.015796172,0.000339932,0.005942794,0.0002860215,0.0010787139,0.00007415141,0.000048203176,0.00040005427],"genre_scores_gemma":[0.99682724,0.0006700467,0.0013427113,0.00051116565,0.00008096282,0.00039149183,0.000032660933,0.00001586045,0.0001278533],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982011,0.000112598325,0.00078274636,0.00029128746,0.00024030446,0.00037197964],"domain_scores_gemma":[0.9988009,0.00046439515,0.00013036618,0.00017449645,0.00009296377,0.0003368963],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000051856096,0.00031968497,0.00088526367,0.00022927455,0.00007624337,0.000067927176,0.000085549524,0.00014416248,0.00010244199],"category_scores_gemma":[0.000092649105,0.0001785592,0.0004033499,0.00016580318,0.00005460858,0.0001504467,0.000026135454,0.00008807862,0.000029302142],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034506223,0.012188237,0.8243033,0.001097597,0.004596138,0.022750434,0.007495048,0.0013313263,0.000504854,0.0013711987,0.028377129,0.09253406],"study_design_scores_gemma":[0.033182014,0.02699245,0.58126503,0.0051655294,0.0029956095,0.024742011,0.0032894348,0.004694334,0.084818415,0.008509746,0.22261222,0.0017332165],"about_ca_topic_score_codex":0.00001137229,"about_ca_topic_score_gemma":0.000014641467,"teacher_disagreement_score":0.24303834,"about_ca_system_score_codex":0.00050241745,"about_ca_system_score_gemma":0.00023748548,"threshold_uncertainty_score":0.72814333},"labels":[],"label_agreement":null},{"id":"W4396869098","doi":"10.1080/09546634.2024.2324833","title":"Efficacy of lebrikizumab in adolescent patients with moderate-to-severe atopic dermatitis: 16-week results from three randomized phase 3 clinical trials","year":2024,"lang":"en","type":"article","venue":"Journal of Dermatological Treatment","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; University of British Columbia","funders":"Eli Lilly and Company","keywords":"Medicine; Atopic dermatitis; Randomized controlled trial; Placebo; Dermatology; Clinical trial; Clinical efficacy; Internal medicine; Alternative medicine; Pathology","score_opus":0.10292422431291924,"score_gpt":0.39480289314384626,"score_spread":0.291878668830927,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396869098","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.989645,0.004051215,0.000914754,0.003007993,0.00033080787,0.0015747392,0.00018527836,0.000032527612,0.00025769748],"genre_scores_gemma":[0.99757504,0.00053510803,0.0010464877,0.0005578851,0.00010954867,0.000032850643,0.00010514856,0.000018452347,0.000019488878],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.993859,0.0015114312,0.0034666306,0.00036266126,0.000501871,0.00029838434],"domain_scores_gemma":[0.9933856,0.004871964,0.0008016749,0.0002973869,0.00021674146,0.00042661547],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010794422,0.00034428146,0.0033663695,0.0002794232,0.00004132691,0.000040342544,0.00015186524,0.00025019466,0.000114227514],"category_scores_gemma":[0.002999127,0.00017596269,0.0009514957,0.00023346543,0.00021418568,0.00013287656,0.0000367869,0.0003874605,0.000029161687],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.67274415,0.02547287,0.23411848,0.00020286466,0.0041098977,0.010390519,0.00042562402,0.0001582105,0.000004134308,0.00012004967,0.0081685195,0.044084657],"study_design_scores_gemma":[0.6362518,0.002121658,0.35348105,0.0023179583,0.002094906,0.00075359934,0.000051348467,0.0005852006,0.00038391023,0.000963426,0.0007691967,0.00022591249],"about_ca_topic_score_codex":0.000014242801,"about_ca_topic_score_gemma":0.0000141575265,"teacher_disagreement_score":0.11936258,"about_ca_system_score_codex":0.0001903068,"about_ca_system_score_gemma":0.00036161128,"threshold_uncertainty_score":0.717555},"labels":[],"label_agreement":null},{"id":"W4396928451","doi":"10.1080/09546634.2024.2349658","title":"Comparative analysis of persistence and remission with guselkumab <i>versus</i> secukinumab and ixekizumab in the United States","year":2024,"lang":"en","type":"article","venue":"Journal of Dermatological Treatment","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"Janssen Biotech","keywords":"Secukinumab; Ixekizumab; Medicine; Persistence (discontinuity); Dermatology; Immunology; Psoriasis; Psoriatic arthritis","score_opus":0.051451101065958495,"score_gpt":0.28894458342242774,"score_spread":0.23749348235646925,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396928451","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.985207,0.013855408,0.000016993126,0.0005633761,0.00005439479,0.00010774055,0.000033575063,0.0000072146645,0.00015429554],"genre_scores_gemma":[0.997068,0.0026754509,0.00013259123,0.000029780063,0.0000042922225,0.000005651523,0.000052823885,0.0000026913635,0.00002874835],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990429,0.00029371682,0.0003125257,0.00015184045,0.000060104303,0.00013888071],"domain_scores_gemma":[0.9990222,0.0006560733,0.00014855154,0.00009492084,0.000052811058,0.000025464968],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013443823,0.00016130015,0.0005520829,0.00031491558,0.00007161418,0.000023533237,0.00008261875,0.00009243492,0.00002826111],"category_scores_gemma":[0.000011156298,0.00006976773,0.00011966734,0.0005603289,0.00018461121,0.00006607173,0.00001701107,0.00011276437,0.000001553795],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.053898472,0.0104337735,0.40210545,0.00054986874,0.14415783,0.012621547,0.2114585,0.0031440242,0.020529307,0.006177322,0.003681305,0.1312426],"study_design_scores_gemma":[0.052853096,0.02955439,0.6232283,0.0014164408,0.05285825,0.01600788,0.09457597,0.0028380507,0.064607546,0.00080264185,0.059777874,0.0014795372],"about_ca_topic_score_codex":0.000028397317,"about_ca_topic_score_gemma":0.00003141524,"teacher_disagreement_score":0.22112288,"about_ca_system_score_codex":0.00005515677,"about_ca_system_score_gemma":0.000034104327,"threshold_uncertainty_score":0.28450453},"labels":[],"label_agreement":null},{"id":"W4399034169","doi":"10.1080/09546634.2024.2350227","title":"Association of disease duration and PASI response rates at week 12 in patients with moderate-to-severe plaque psoriasis receiving biologics in the real-world psoriasis study of health outcomes (PSoHO)","year":2024,"lang":"en","type":"article","venue":"Journal of Dermatological Treatment","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; University of Toronto","funders":"","keywords":"Medicine; Plaque psoriasis; Psoriasis; Dermatology; Psoriasis Area and Severity Index","score_opus":0.02965685294977767,"score_gpt":0.28558827444117285,"score_spread":0.2559314214913952,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399034169","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957227,0.0008283318,0.0000041656467,0.0023666685,0.00018690841,0.0007865368,0.00007871023,0.000010661607,0.000015310303],"genre_scores_gemma":[0.9990613,0.0006045784,0.00007880342,0.00005132722,0.000007934623,0.000049401835,0.000037377034,0.000009208257,0.00010010887],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9959277,0.002350063,0.0010835001,0.0002453271,0.00014012269,0.0002532665],"domain_scores_gemma":[0.9973608,0.0016672001,0.00067586236,0.00016189626,0.000089022484,0.000045179444],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010497668,0.00024695473,0.00081677083,0.00037601375,0.00010948058,0.000021659711,0.00011964183,0.00012714895,0.0000178145],"category_scores_gemma":[0.00023655273,0.00012319992,0.000114780545,0.00035012458,0.00003966603,0.00011632605,0.000036032714,0.00014089131,0.0000029684766],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010910445,0.0029310535,0.9783278,0.00002783983,0.0006352889,0.000063993095,0.0032445143,0.00009646716,0.00007031979,0.00002640779,0.00008957225,0.0035762733],"study_design_scores_gemma":[0.006658432,0.0041567227,0.9872164,0.00013582125,0.00023601418,0.000012128562,0.0009423903,0.0000055308005,0.00036518226,0.000079686375,0.00007969572,0.00011197398],"about_ca_topic_score_codex":0.00013070804,"about_ca_topic_score_gemma":0.0010057618,"teacher_disagreement_score":0.008888597,"about_ca_system_score_codex":0.0005363872,"about_ca_system_score_gemma":0.0001107848,"threshold_uncertainty_score":0.50239474},"labels":[],"label_agreement":null},{"id":"W4400174824","doi":"10.1080/09546634.2024.2371045","title":"Deucravacitinib onset of action and maintenance of response in phase 3 plaque psoriasis trials","year":2024,"lang":"en","type":"article","venue":"Journal of Dermatological Treatment","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; Queen's University","funders":"","keywords":"Medicine; Placebo; Psoriasis; Apremilast; Plaque psoriasis; Onset of action; Internal medicine; Clinical trial; Randomized controlled trial; Gastroenterology; Dermatology; Pathology","score_opus":0.08820321456382156,"score_gpt":0.3608091798270552,"score_spread":0.2726059652632336,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400174824","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98682326,0.01157617,0.00008200319,0.00063642574,0.00044493692,0.00020405912,0.00017693029,0.000010439786,0.00004579374],"genre_scores_gemma":[0.99564517,0.003894025,0.00028893753,0.000013586951,0.000018825907,0.000013494819,0.000013620759,0.000006993915,0.000105336374],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99731755,0.0011967198,0.0010916167,0.00015893536,0.000053756965,0.00018142154],"domain_scores_gemma":[0.9973081,0.0019898226,0.0004928438,0.0001126335,0.00006292805,0.00003370012],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009903593,0.00018295209,0.0010336242,0.00030224444,0.000029723911,0.000008543383,0.000080085854,0.000228018,0.0001262852],"category_scores_gemma":[0.0004250929,0.00010611034,0.0003013723,0.00016454075,0.00013336953,0.00008778274,0.000016897618,0.000121060126,0.0000088999395],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.10210231,0.006575477,0.030948468,0.00028432388,0.005266714,0.004242591,0.0026566107,0.000025732272,0.50161,0.0011299772,0.002187631,0.34297016],"study_design_scores_gemma":[0.028506808,0.008470643,0.045674402,0.0007321682,0.001243388,0.008657923,0.0010505542,0.000017146156,0.8934204,0.0012339812,0.010725836,0.00026674953],"about_ca_topic_score_codex":0.000011897069,"about_ca_topic_score_gemma":0.00000583788,"teacher_disagreement_score":0.3918104,"about_ca_system_score_codex":0.00009509503,"about_ca_system_score_gemma":0.000117913936,"threshold_uncertainty_score":0.4327054},"labels":[],"label_agreement":null},{"id":"W4403287791","doi":"10.1080/09546634.2024.2414048","title":"A systematic review of recent randomized controlled trials for palmoplantar pustulosis","year":2024,"lang":"en","type":"review","venue":"Journal of Dermatological Treatment","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dermatrials Research; McMaster University","funders":"","keywords":"Palmoplantar pustulosis; Medicine; Randomized controlled trial; Dermatology; Quality of life (healthcare); Incidence (geometry); Psoriasis; Intensive care medicine; Surgery","score_opus":0.13774116053334678,"score_gpt":0.38436744412217355,"score_spread":0.24662628358882677,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403287791","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000004568714,0.9820999,0.000029870662,0.00023922478,0.0016414818,0.01524942,0.0005728971,0.000024790255,0.00013783788],"genre_scores_gemma":[0.000009996761,0.99490225,0.00018481918,0.000058270805,0.0000874933,0.003908372,0.0003194425,0.000039367205,0.00048996275],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.97968894,0.009802849,0.009621818,0.0003553903,0.00015489207,0.00037612917],"domain_scores_gemma":[0.9714525,0.018263875,0.009443616,0.0003938196,0.00037260918,0.00007360071],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":["metaepi_broad"],"category_scores_codex":[0.007316333,0.0009879987,0.052242022,0.00045243432,0.00007622178,0.000027923823,0.00039416293,0.00077816367,0.00037996095],"category_scores_gemma":[0.008177545,0.0003617471,0.017802965,0.00024437936,0.00013719263,0.00004001097,0.000042235493,0.00026735093,0.0001212676],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018623771,0.00081367925,2.6040908e-7,0.83566076,0.09290244,0.00023038742,0.000035211273,3.6384428e-8,0.0000018126436,0.00021160748,0.0024912637,0.049028788],"study_design_scores_gemma":[0.1068115,0.0005180901,1.629689e-8,0.4868042,0.28109834,0.003150832,0.00001635713,1.3967518e-7,0.00003386987,0.00009345682,0.12125359,0.00021961993],"about_ca_topic_score_codex":0.000001248978,"about_ca_topic_score_gemma":3.2430333e-7,"teacher_disagreement_score":0.34885657,"about_ca_system_score_codex":0.00030165698,"about_ca_system_score_gemma":0.00047343105,"threshold_uncertainty_score":0.9998835},"labels":[],"label_agreement":null},{"id":"W4404014696","doi":"10.1080/09546634.2024.2422909","title":"Complete responses and SALT zero scores in alopecia areata: not the same","year":2024,"lang":"en","type":"article","venue":"Journal of Dermatological Treatment","topic":"Hair Growth and Disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Community Based Research Centre; University of British Columbia","funders":"","keywords":"Alopecia areata; Medicine; Dermatology","score_opus":0.061284090668735275,"score_gpt":0.3228784799423942,"score_spread":0.26159438927365897,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404014696","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9671987,0.010125847,0.00006946306,0.021582127,0.00010111141,0.000189134,0.000015438882,0.000017342392,0.0007008017],"genre_scores_gemma":[0.9966643,0.0016710132,0.00029809042,0.0011624554,0.00005404336,0.0000071934264,0.0000031466277,0.0000071570857,0.00013262656],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990163,0.00011491231,0.00036923806,0.00012351185,0.00019546112,0.00018061229],"domain_scores_gemma":[0.9991038,0.0005679253,0.000055423803,0.000104074745,0.000031409258,0.00013738032],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014978602,0.00013507287,0.00039065056,0.00013431702,0.000048765814,0.00004759938,0.000059764643,0.00006211214,0.000042915104],"category_scores_gemma":[0.00016873836,0.00005865584,0.00013052575,0.00014003771,0.00012649386,0.000064390726,0.00002180256,0.0001788334,0.000018102195],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006761523,0.0015597306,0.87222093,0.000280542,0.00091057393,0.03970636,0.0028060982,0.000028428385,0.002476908,0.0069966656,0.010913882,0.055338334],"study_design_scores_gemma":[0.005899676,0.0027155566,0.8729794,0.00063891464,0.0003696193,0.019709922,0.00070391403,0.00030557116,0.0012386487,0.0043375436,0.090892866,0.000208355],"about_ca_topic_score_codex":0.00001565881,"about_ca_topic_score_gemma":0.000022670534,"teacher_disagreement_score":0.07997898,"about_ca_system_score_codex":0.00007900852,"about_ca_system_score_gemma":0.000104494306,"threshold_uncertainty_score":0.23919159},"labels":[],"label_agreement":null},{"id":"W4405252165","doi":"10.1080/09546634.2024.2428729","title":"Real-world evidence on the benefits of optimal itch relief and skin clearance in atopic dermatitis management: a study from the TARGET-DERM AD registry","year":2024,"lang":"en","type":"article","venue":"Journal of Dermatological Treatment","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; SKiN Health; Queen's University","funders":"","keywords":"Medicine; Atopic dermatitis; Dermatology","score_opus":0.03976122395500714,"score_gpt":0.31264000543240145,"score_spread":0.2728787814773943,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405252165","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9581198,0.024258211,0.00000617604,0.01624565,0.00011547046,0.000562802,0.00001507058,0.000016443986,0.0006603693],"genre_scores_gemma":[0.98873734,0.010136433,0.0003651705,0.00054250646,0.0000429737,0.00003831343,0.0000023691168,0.000010017778,0.00012486069],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99830073,0.00029644184,0.0006401434,0.0002265989,0.00033798814,0.00019811453],"domain_scores_gemma":[0.99807703,0.0012471728,0.00021109958,0.00032851796,0.000044641623,0.00009151879],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021559157,0.00020290646,0.00055292895,0.00010170562,0.00008843177,0.00004248778,0.00020762354,0.00007441663,0.00007551556],"category_scores_gemma":[0.00010827337,0.00009183459,0.00017583807,0.0002556267,0.00016494314,0.00010410372,0.000062256055,0.000299131,0.00001174937],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000927545,0.0025424834,0.9563077,0.00023717455,0.0013047839,0.011655656,0.0022656557,0.0000942828,0.000010461257,0.0020742232,0.010375168,0.012204858],"study_design_scores_gemma":[0.0012217647,0.0004138311,0.9919289,0.0017132834,0.00039398283,0.00062430446,0.0011731614,0.00013021899,0.0003860117,0.0006419988,0.0012877379,0.000084812506],"about_ca_topic_score_codex":0.000039782753,"about_ca_topic_score_gemma":0.000027740516,"teacher_disagreement_score":0.035621185,"about_ca_system_score_codex":0.00008808116,"about_ca_system_score_gemma":0.000055463624,"threshold_uncertainty_score":0.3744906},"labels":[],"label_agreement":null},{"id":"W4407358806","doi":"10.1080/09546634.2025.2464107","title":"Oral roflumilast for psoriasis: a real-world 24-week prospective cohort study","year":2025,"lang":"en","type":"article","venue":"Journal of Dermatological Treatment","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Medicine; Roflumilast; Psoriasis; Prospective cohort study; Cohort; Cohort study; Dermatology; Internal medicine; COPD","score_opus":0.03453545310000239,"score_gpt":0.30395596781091644,"score_spread":0.26942051471091405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407358806","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98949474,0.002441044,0.00016733466,0.00057401916,0.0018390507,0.0020874704,0.00006164804,0.000062297375,0.003272417],"genre_scores_gemma":[0.9938397,0.0003656051,0.0005519678,0.00008314627,0.00006485867,0.0004344186,0.000027349804,0.000014653637,0.0046183183],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99790347,0.00038983638,0.00083573797,0.00036679313,0.00008130314,0.0004228446],"domain_scores_gemma":[0.998528,0.0004776201,0.00042234184,0.0002696493,0.0002454212,0.00005698969],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030785575,0.00037576107,0.0011439341,0.0003155407,0.00028635215,0.000033589196,0.00024448446,0.00020902108,0.000118948854],"category_scores_gemma":[0.00009356908,0.00023042587,0.0005130505,0.00032320962,0.0001101433,0.00010318116,0.000049231556,0.00016816723,0.00005785946],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025879722,0.0075875167,0.96615463,0.000014094575,0.0062073213,0.00025280917,0.00031104972,0.0000053965423,0.0006107588,0.0012789103,0.0050862124,0.009903338],"study_design_scores_gemma":[0.018786063,0.0056147096,0.93693775,0.00006602526,0.003133881,0.00032601308,0.0009459649,0.0000022820814,0.018218042,0.0015479104,0.014130211,0.00029116962],"about_ca_topic_score_codex":0.00004735863,"about_ca_topic_score_gemma":0.00014194341,"teacher_disagreement_score":0.029216895,"about_ca_system_score_codex":0.00041218303,"about_ca_system_score_gemma":0.00017246713,"threshold_uncertainty_score":0.9396494},"labels":[],"label_agreement":null},{"id":"W4407947855","doi":"10.1080/09546634.2025.2471451","title":"Epidemiology, genetics and management of vitiligo in the USA: an All of Us investigation","year":2025,"lang":"en","type":"article","venue":"Journal of Dermatological Treatment","topic":"melanin and skin pigmentation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Mediprobe Research (Canada); University of Toronto","funders":"","keywords":"Vitiligo; Medicine; Epidemiology; Disease management; Gerontology; Genetics; Dermatology; Alternative medicine; Pathology; Health management system; Biology","score_opus":0.06927202649355424,"score_gpt":0.3667290324503358,"score_spread":0.29745700595678154,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407947855","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973207,0.0016235012,0.00027351524,0.00043368386,0.00003106426,0.00012095913,0.0000025797367,4.072722e-7,0.0001936043],"genre_scores_gemma":[0.9926248,0.003517436,0.0035109643,0.0003087351,0.0000091663605,0.0000052615974,0.000011481915,0.0000013996647,0.000010753886],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999147,0.00024690203,0.00039943168,0.00008030919,0.000056645807,0.00006971521],"domain_scores_gemma":[0.99957633,0.00005362733,0.00021331021,0.000099849145,0.000031432868,0.00002547699],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002780862,0.00006571253,0.00019032166,0.000037818223,0.000012684916,0.0000019418735,0.00008408801,0.00006860614,0.000002046705],"category_scores_gemma":[0.000023849354,0.00003719918,0.00004871208,0.00004529215,0.00008319743,0.0000027606895,0.000020424513,0.000030613337,1.1159256e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000107037056,0.00029721463,0.9720499,0.00005811308,0.0001757021,0.000029162782,0.00010619271,0.00014351902,0.021652834,0.0019173096,0.00013211153,0.0033309218],"study_design_scores_gemma":[0.0011637573,0.00091155496,0.8986011,0.000045729743,0.00009618388,0.000113470946,0.0002840139,0.00008388251,0.09599823,0.0019964066,0.00066065864,0.000044972086],"about_ca_topic_score_codex":0.000010186904,"about_ca_topic_score_gemma":0.000022103479,"teacher_disagreement_score":0.07434539,"about_ca_system_score_codex":0.000010977514,"about_ca_system_score_gemma":0.000014953498,"threshold_uncertainty_score":0.15169385},"labels":[],"label_agreement":null},{"id":"W4408516286","doi":"10.1080/09546634.2025.2479126","title":"Topical delgocitinib for the treatment of chronic hand eczema","year":2025,"lang":"en","type":"review","venue":"Journal of Dermatological Treatment","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Medicine; Dermatology; Hand eczema; Allergy; Contact dermatitis; Immunology","score_opus":0.08650470726124279,"score_gpt":0.4029417386772591,"score_spread":0.3164370314160163,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408516286","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00019356117,0.99629027,0.00021742351,0.0008617836,0.0003849222,0.0016415386,0.000098929755,0.000010279919,0.00030131743],"genre_scores_gemma":[0.0010598827,0.9973117,0.0003238738,0.000075111355,0.00029904448,0.00025537258,0.000045823337,0.000015377083,0.0006137944],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99772245,0.00019087883,0.001344244,0.00022972973,0.00021219543,0.00030050692],"domain_scores_gemma":[0.9957536,0.0027081387,0.00082525075,0.0003707088,0.0001658137,0.00017651313],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000074906646,0.00046212744,0.0035786785,0.00016719781,0.00013503704,0.000020490592,0.00020293544,0.0004292194,0.0001024909],"category_scores_gemma":[0.00016519064,0.0001870885,0.0027640415,0.00014695122,0.0002810705,0.00002680575,0.000020486168,0.00015475242,0.000007530759],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003374234,0.0036415313,0.0004922446,0.007890686,0.0042446167,0.001334846,0.000039451614,0.0000012794578,1.7984111e-7,0.00020591558,0.004109854,0.97770196],"study_design_scores_gemma":[0.0037583413,0.0036179586,0.00017769584,0.005374206,0.01319647,0.0060478724,0.000019102621,0.000008264014,0.00005532656,0.00012594111,0.96748716,0.0001316619],"about_ca_topic_score_codex":0.0000015996698,"about_ca_topic_score_gemma":0.0000019164872,"teacher_disagreement_score":0.9775703,"about_ca_system_score_codex":0.0004906305,"about_ca_system_score_gemma":0.001059446,"threshold_uncertainty_score":0.7629248},"labels":[],"label_agreement":null},{"id":"W4408914407","doi":"10.1080/09546634.2025.2482009","title":"The impact of cannabis use on local anesthetic dosing during hair restoration surgery: a case report, proposed mechanisms, and clinical recommendations","year":2025,"lang":"en","type":"review","venue":"Journal of Dermatological Treatment","topic":"Cannabis and Cannabinoid Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mediprobe Research (Canada); University of Toronto","funders":"","keywords":"Medicine; Dosing; Cannabis; Local anesthetic; Anesthetic; Anesthesia; Surgery; Intensive care medicine; Psychiatry; Pharmacology","score_opus":0.10653375380628648,"score_gpt":0.443578762879763,"score_spread":0.3370450090734765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408914407","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.042571776,0.94500685,0.00016585433,0.009319867,0.0003705157,0.0024224427,0.0000781685,0.000026841572,0.00003768828],"genre_scores_gemma":[0.00934768,0.9893866,0.00020730786,0.000018742481,0.000073617186,0.00004311475,0.000040983305,0.000024247647,0.00085770903],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.995756,0.0009852669,0.002242838,0.00030444268,0.00040003005,0.00031146605],"domain_scores_gemma":[0.99652463,0.0007071566,0.0016054119,0.0004305221,0.00039455143,0.00033773555],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010419814,0.0003769208,0.0023958762,0.00037113598,0.0002842759,0.000096086274,0.00008883744,0.0003419954,0.000015435951],"category_scores_gemma":[0.0012119028,0.00016746223,0.0016709619,0.00034574093,0.00024180782,0.000079996644,0.000051738018,0.0006256179,9.383308e-7],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00078633794,0.0017423506,0.0007978217,0.0029111868,0.001671436,0.19387089,0.000036380818,0.0000068927993,9.750796e-7,0.00009982408,0.012953909,0.785122],"study_design_scores_gemma":[0.0018518793,0.0038722127,0.0015765969,0.013539098,0.0027447627,0.79283166,0.00012769073,0.000043382304,0.00002868823,0.00009222509,0.18300994,0.0002818702],"about_ca_topic_score_codex":0.00015414954,"about_ca_topic_score_gemma":0.000031699346,"teacher_disagreement_score":0.7848401,"about_ca_system_score_codex":0.0010623777,"about_ca_system_score_gemma":0.0023009893,"threshold_uncertainty_score":0.6828912},"labels":[],"label_agreement":null},{"id":"W4411022782","doi":"10.1080/09546634.2025.2513054","title":"A network meta-analysis study of monotherapies for hidradenitis suppurativa: analyses of the current evidence base","year":2025,"lang":"en","type":"review","venue":"Journal of Dermatological Treatment","topic":"Hidradenitis Suppurativa and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mediprobe Research (Canada); Women's College Hospital; University of Toronto","funders":"","keywords":"Hidradenitis suppurativa; Medicine; Dermatology; Base (topology); Meta-analysis; Internal medicine; Disease","score_opus":0.5825344248372164,"score_gpt":0.5209130035748681,"score_spread":0.061621421262348264,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411022782","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00030780226,0.99465877,0.00018157603,0.0012527963,0.00014755024,0.0031981356,0.00022280504,0.00000777974,0.000022796816],"genre_scores_gemma":[0.16541237,0.8332428,0.0007063359,0.0000046209257,0.000064842374,0.00038245108,0.000024023459,0.000019503235,0.00014310777],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99427587,0.0014019856,0.002889694,0.00039930185,0.00071864575,0.00031447597],"domain_scores_gemma":[0.99205756,0.003266018,0.003297616,0.0007270514,0.00049811264,0.00015362553],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.000052629624,0.0007276439,0.010807668,0.0005454268,0.0001289453,0.000026520696,0.00042077963,0.00019538503,0.00013713365],"category_scores_gemma":[0.00037425492,0.00028885916,0.010298141,0.0015958911,0.00014800769,0.00010989225,0.000080663136,0.0003331346,0.0000011825668],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043133946,0.0108557325,0.0047148895,0.008498009,0.79992086,0.0055141333,0.00050065963,0.000029197403,0.0000011186131,0.000042352607,0.00046011133,0.16903162],"study_design_scores_gemma":[0.0021661462,0.0035547388,0.00020042434,0.004529437,0.97174853,0.00627352,0.00014522196,0.000006628341,0.000041564992,0.000116536736,0.011000628,0.00021663772],"about_ca_topic_score_codex":0.00001922211,"about_ca_topic_score_gemma":0.000018121676,"teacher_disagreement_score":0.17182769,"about_ca_system_score_codex":0.0002475126,"about_ca_system_score_gemma":0.00068619347,"threshold_uncertainty_score":0.99995637},"labels":[],"label_agreement":null},{"id":"W4411026382","doi":"10.1080/09546634.2025.2504655","title":"Fractional microneedle radiofrequency with the application of vitamin C, E, and ferulic acid serum for neck skin rejuvenation: a prospective, double-blinded, split-neck, placebo-controlled trial","year":2025,"lang":"en","type":"article","venue":"Journal of Dermatological Treatment","topic":"Dermatologic Treatments and Research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health; University of British Columbia","funders":"Yonsei University","keywords":"Medicine; Rejuvenation; Ferulic acid; Placebo; Double blinded; Vitamin C; Prospective cohort study; Surgery; Dermatology; Internal medicine; Pathology","score_opus":0.02463840288458526,"score_gpt":0.3330529627077151,"score_spread":0.3084145598231299,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411026382","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97541827,0.0017541605,0.0014057587,0.013813107,0.00009080003,0.006029351,0.000016393404,0.000016085281,0.0014560559],"genre_scores_gemma":[0.99498963,0.00026510502,0.003160015,0.00014666677,0.00007297231,0.0008654162,0.0000108131735,0.000009694095,0.00047969064],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9983923,0.00009525294,0.0006672114,0.00024167965,0.00036480709,0.00023876828],"domain_scores_gemma":[0.99840486,0.0003841917,0.0005117012,0.00020663209,0.00038209805,0.00011049879],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023522605,0.00023201144,0.0009246563,0.00019061496,0.00017521578,0.000037694997,0.00011440222,0.00016422161,0.000022733875],"category_scores_gemma":[0.00005873133,0.00010020977,0.00028487752,0.00024874866,0.00018394315,0.000100066,0.000022296183,0.00020321217,0.0000018832501],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9162432,0.00656359,0.04264952,0.00021691757,0.004085659,0.00026742817,0.00027301244,0.000030424482,0.0013994313,0.0076658367,0.0015326086,0.019072354],"study_design_scores_gemma":[0.9290846,0.0063231336,0.037569277,0.00015784937,0.0012289294,0.00322284,0.00037291585,0.00027818658,0.012289482,0.0011781947,0.008123223,0.00017134254],"about_ca_topic_score_codex":0.0000075339913,"about_ca_topic_score_gemma":0.0000033700694,"teacher_disagreement_score":0.01957134,"about_ca_system_score_codex":0.00026650185,"about_ca_system_score_gemma":0.00032111484,"threshold_uncertainty_score":0.4086436},"labels":[],"label_agreement":null},{"id":"W4412063952","doi":"10.1080/09546634.2025.2526073","title":"Global onychomycosis management and the challenges of antifungal stewardship","year":2025,"lang":"en","type":"review","venue":"Journal of Dermatological Treatment","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mediprobe Research (Canada); University of Toronto","funders":"","keywords":"Medicine; Antifungal; Stewardship (theology); Intensive care medicine; Dermatology","score_opus":0.06682672204896437,"score_gpt":0.37040779014517705,"score_spread":0.30358106809621266,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412063952","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00022116587,0.992692,0.000004951476,0.0005709075,0.00013501283,0.0010483476,0.00008022395,0.000008643701,0.0052387556],"genre_scores_gemma":[0.0064561977,0.99292296,0.00032997745,0.000039411527,0.000044450477,0.00005198908,0.000008726475,0.000009098899,0.00013716979],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979024,0.00030887796,0.0009817843,0.0002317861,0.00036694942,0.0002082053],"domain_scores_gemma":[0.9982431,0.0004003176,0.0007817624,0.00030799245,0.000086306914,0.00018051485],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014547123,0.00041164758,0.0030685295,0.00013541376,0.00005325214,0.000018949171,0.00015787623,0.00018843147,0.000021878344],"category_scores_gemma":[0.000049720824,0.00016452339,0.0014360665,0.0001925697,0.00017120449,0.000028441234,0.00008823654,0.00012751567,0.000004078157],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005242535,0.0016829966,0.0019784556,0.015843438,0.007758669,0.0023753368,0.000014085123,1.3430177e-7,2.5517382e-9,0.008583246,0.00029561308,0.96094376],"study_design_scores_gemma":[0.033249136,0.003535065,0.017675843,0.07631205,0.09963504,0.014720617,0.0003179022,0.0000019815827,0.0000021217181,0.0037223229,0.7502892,0.0005387075],"about_ca_topic_score_codex":0.0000029060905,"about_ca_topic_score_gemma":7.0672365e-7,"teacher_disagreement_score":0.96040505,"about_ca_system_score_codex":0.0002644966,"about_ca_system_score_gemma":0.00018160728,"threshold_uncertainty_score":0.6709069},"labels":[],"label_agreement":null},{"id":"W4412197636","doi":"10.1080/09546634.2025.2525287","title":"Efficacy of oral isotretinoin monotherapy compared to combination isotretinoin and topical clascoterone for severe acne vulgaris: a multi-center retrospective study","year":2025,"lang":"en","type":"article","venue":"Journal of Dermatological Treatment","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; McMaster University","funders":"","keywords":"Medicine; Isotretinoin; Acne; Dermatology; Retrospective cohort study; Surgery","score_opus":0.03661990874853594,"score_gpt":0.3554664952659496,"score_spread":0.31884658651741365,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412197636","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927816,0.00035472706,0.0014147236,0.0035400968,0.00010853069,0.001699594,0.000014716886,0.000013776371,0.00007225043],"genre_scores_gemma":[0.99510276,0.00010342197,0.004146189,0.00031561978,0.00002391816,0.000041814343,0.000009998842,0.000008998416,0.00024726495],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987159,0.00011630055,0.0005658487,0.00022454221,0.00017857613,0.00019887755],"domain_scores_gemma":[0.99916446,0.00014226593,0.00022218924,0.00014834265,0.00017816744,0.00014457821],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011355196,0.00022391573,0.0009417518,0.00014703439,0.00008483222,0.000020030107,0.000064925174,0.00011082777,0.000015475774],"category_scores_gemma":[0.00007894094,0.00012758633,0.0002129087,0.00013186401,0.000053011856,0.000049370083,0.000032016793,0.00011345695,0.0000015172661],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007546644,0.024518745,0.9531865,0.000061884064,0.0016057745,0.00021558019,0.0013314988,0.000009848308,0.0005035833,0.00012345087,0.0011921718,0.009704316],"study_design_scores_gemma":[0.07055797,0.0141952885,0.9101135,0.00022747909,0.00063185126,0.0002577144,0.00056319946,0.00032304836,0.0019900824,0.00010691554,0.0009032546,0.00012970857],"about_ca_topic_score_codex":0.000015311716,"about_ca_topic_score_gemma":0.000009077344,"teacher_disagreement_score":0.063011326,"about_ca_system_score_codex":0.00020447014,"about_ca_system_score_gemma":0.000047332174,"threshold_uncertainty_score":0.520282},"labels":[],"label_agreement":null},{"id":"W4412422999","doi":"10.1080/09546634.2025.2523373","title":"The hf-PGA is a valid and reliable measure of hand/foot psoriasis severity in adults: results from a phase 2b clinical trial","year":2025,"lang":"en","type":"article","venue":"Journal of Dermatological Treatment","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dermatrials Research; Innovaderm (Canada)","funders":"","keywords":"Medicine; Psoriasis; Foot (prosody); Clinical trial; Physical therapy; Dermatology; Measure (data warehouse); Physical medicine and rehabilitation; Surgery; Internal medicine; Data mining","score_opus":0.06067050228900951,"score_gpt":0.34320144719193957,"score_spread":0.28253094490293007,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412422999","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98118645,0.0142662665,0.000016191021,0.0022542775,0.0011359783,0.00048768922,0.00030861507,0.000010703567,0.00033380045],"genre_scores_gemma":[0.992476,0.006773297,0.0002468345,0.000119704884,0.00006735386,0.000028931518,0.00003530787,0.0000064851365,0.0002460835],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9967081,0.00087925,0.0016875132,0.00032543682,0.00009750562,0.0003021733],"domain_scores_gemma":[0.9967375,0.0019856442,0.00074614596,0.00032336375,0.00014949816,0.00005788494],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008237703,0.0002723902,0.0010694348,0.0001146591,0.00023463502,0.000030378858,0.0002382965,0.0004686637,0.00004160399],"category_scores_gemma":[0.00067542546,0.00014310359,0.00044612976,0.00020244073,0.00033623373,0.00007434292,0.00006313642,0.00028759195,0.000008862399],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.59288925,0.0131041715,0.077753596,0.0000359397,0.0059461566,0.000607861,0.0018755727,0.0000030292672,0.0013979346,0.00020224265,0.010941393,0.29524285],"study_design_scores_gemma":[0.7812441,0.012051567,0.06994463,0.0009563694,0.0023924191,0.00041472176,0.001285907,0.000024458112,0.05035933,0.003173403,0.077663586,0.0004894915],"about_ca_topic_score_codex":0.00012098012,"about_ca_topic_score_gemma":0.000066523135,"teacher_disagreement_score":0.29475334,"about_ca_system_score_codex":0.00009911034,"about_ca_system_score_gemma":0.00019650614,"threshold_uncertainty_score":0.5835595},"labels":[],"label_agreement":null},{"id":"W4412654198","doi":"10.1080/09546634.2025.2492188","title":"Lebrikizumab improves head/neck/face dermatitis and erythema and does not increase treatment-emergent adverse events of head/neck/face erythema in patients with moderate-to-severe atopic dermatitis","year":2025,"lang":"en","type":"article","venue":"Journal of Dermatological Treatment","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health; University of British Columbia","funders":"Dermira; Eli Lilly and Company","keywords":"Medicine; Erythema; Dermatology; Atopic dermatitis; Adverse effect; Eczema Area and Severity Index; Placebo; Head and neck; Internal medicine; Surgery; Pathology","score_opus":0.011213966246588164,"score_gpt":0.2672021434311173,"score_spread":0.25598817718452915,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412654198","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931311,0.0016899753,0.00007198135,0.0035266855,0.00011090643,0.0011266519,0.0001195774,0.000026596952,0.00019649719],"genre_scores_gemma":[0.99585986,0.0012444601,0.001597887,0.0009425724,0.000016705397,0.00006786536,0.00003409242,0.000022268583,0.00021427544],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973316,0.00023559763,0.0011403186,0.0004274893,0.00039136063,0.00047359947],"domain_scores_gemma":[0.99825287,0.00024200926,0.0004634138,0.00034165542,0.00020162054,0.00049842225],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00007556383,0.0005412268,0.0015413077,0.00038810613,0.00015071606,0.000019584215,0.00013056089,0.00022758036,0.000047187128],"category_scores_gemma":[0.00012282602,0.00031167074,0.0002292766,0.00025818765,0.00019238966,0.0002822075,0.00009381315,0.0001882471,0.0000050542994],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025426387,0.0036598893,0.98314154,0.00039288387,0.0009337134,0.0013073701,0.0006259521,0.00005648957,0.000035424484,0.00006901833,0.00034886634,0.00688623],"study_design_scores_gemma":[0.022564203,0.0019391199,0.9664877,0.0010890167,0.0006971903,0.0019176934,0.000578755,0.00019675057,0.00342343,0.0003180768,0.00049129175,0.00029678122],"about_ca_topic_score_codex":0.00009099664,"about_ca_topic_score_gemma":0.00011054343,"teacher_disagreement_score":0.020021563,"about_ca_system_score_codex":0.00030597698,"about_ca_system_score_gemma":0.00023409443,"threshold_uncertainty_score":0.99993354},"labels":[],"label_agreement":null},{"id":"W4413113011","doi":"10.1080/09546634.2025.2541970","title":"Effectiveness of double-layer artificial dermis repair material combined with autologous skin patch in repairing deep skin and soft tissue defects: a retrospective study","year":2025,"lang":"en","type":"article","venue":"Journal of Dermatological Treatment","topic":"Wound Healing and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Dermis; Medicine; Artificial skin; Skin grafting; Soft tissue; Surgery; Skin repair; Wound healing; Pathology","score_opus":0.01982860065848656,"score_gpt":0.317454431385622,"score_spread":0.29762583072713544,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413113011","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99769574,0.00032734388,0.00010426448,0.00017011803,0.00013848783,0.001314537,0.0000044080875,0.000050022507,0.00019506135],"genre_scores_gemma":[0.9988242,0.000043014927,0.0009699509,0.00001921107,0.000026874644,0.00007530747,0.000005271461,0.000014800268,0.000021405318],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99784166,0.00040664122,0.00081365707,0.0003513304,0.00029322278,0.00029350168],"domain_scores_gemma":[0.9988172,0.0002928476,0.00034148348,0.00023344424,0.00018668441,0.00012836269],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042579157,0.00030559025,0.0013731613,0.00027615187,0.000096741525,0.000024447667,0.00006212476,0.00016990214,0.000013381206],"category_scores_gemma":[0.000076131415,0.0001810552,0.00016987722,0.000310575,0.00011171689,0.000066425186,0.000040502473,0.00020732949,0.0000015584496],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.021822123,0.006898842,0.9605647,0.0002835952,0.0012593603,0.006197749,0.00068075885,0.000034711662,0.0005057973,0.00018458992,0.0000054519587,0.0015623581],"study_design_scores_gemma":[0.020647012,0.014497555,0.92758834,0.00070282986,0.0009437426,0.0013418349,0.00061253575,0.000071796,0.03282762,0.0006097194,0.000012944066,0.00014409162],"about_ca_topic_score_codex":0.00025106207,"about_ca_topic_score_gemma":0.00015046842,"teacher_disagreement_score":0.032976344,"about_ca_system_score_codex":0.00055801385,"about_ca_system_score_gemma":0.00016224493,"threshold_uncertainty_score":0.73832166},"labels":[],"label_agreement":null},{"id":"W4414289720","doi":"10.1080/09546634.2023.2253942","title":"TNF-alpha inhibitor therapy for granuloma annulare","year":2025,"lang":"en","type":"review","venue":"Journal of Dermatological Treatment","topic":"Skin Diseases and Diabetes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health","funders":"","keywords":"Etanercept; Granuloma annulare; Infliximab; Granuloma; Immunopathology","score_opus":0.07403467192425874,"score_gpt":0.3996113485249058,"score_spread":0.3255766766006471,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414289720","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00037715374,0.9968075,0.00002147513,0.00041868232,0.00037254856,0.0015454668,0.00016371417,0.000024417543,0.00026905545],"genre_scores_gemma":[0.00021021473,0.9977042,0.00076012436,0.00029468193,0.0004510872,0.00018660874,0.00011039918,0.000026016654,0.000256634],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99800074,0.00012105141,0.001051474,0.00025203073,0.00026584984,0.0003088419],"domain_scores_gemma":[0.99774826,0.00079488463,0.0006637625,0.00026455038,0.00022287908,0.0003056814],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009244423,0.00048269544,0.0032604448,0.0002497995,0.00007322393,0.00003731582,0.00015680982,0.0003748067,0.00008787683],"category_scores_gemma":[0.00022536267,0.00023262082,0.0029414054,0.00019176077,0.00005265182,0.00004399453,0.000024211051,0.00019031214,0.000010664121],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002334519,0.0014989097,0.0004982714,0.006852984,0.0013993727,0.0010253143,0.000008618679,8.192156e-8,2.6832112e-7,0.00005823421,0.008636429,0.97978806],"study_design_scores_gemma":[0.0039468054,0.0022690883,0.00019221839,0.013525428,0.0036429297,0.001449101,0.000014872658,5.673244e-7,0.000030839863,0.00023034097,0.97450906,0.00018876199],"about_ca_topic_score_codex":4.7360356e-7,"about_ca_topic_score_gemma":9.623063e-8,"teacher_disagreement_score":0.9795993,"about_ca_system_score_codex":0.00024443198,"about_ca_system_score_gemma":0.000655315,"threshold_uncertainty_score":0.9486002},"labels":[],"label_agreement":null},{"id":"W4415040496","doi":"10.1080/09546634.2025.2555984","title":"Assessment of vitiligo in clinical practice: a cross-sectional survey among experts","year":2025,"lang":"en","type":"article","venue":"Journal of Dermatological Treatment","topic":"melanin and skin pigmentation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital; SKiN Health","funders":"LEO Pharma; Incyte; Les Laboratories Pierre Fabre; Sanofi; Vlaamse regering; Pfizer; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Vitiligo; Clinical Practice; MEDLINE; Clinical trial; Quality of life (healthcare); Depigmentation","score_opus":0.051481684810737074,"score_gpt":0.4677310750810004,"score_spread":0.41624939027026336,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415040496","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99681664,0.00038385214,0.00079373433,0.00007849032,0.00027920213,0.000114473434,0.00000789759,0.0000014979131,0.0015241936],"genre_scores_gemma":[0.9970997,0.00048856484,0.0021101316,0.00013381007,0.00004585055,0.000008322086,0.000030001027,0.0000032751213,0.00008036088],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981937,0.00046952,0.00089986925,0.00015581325,0.00017143147,0.000109669374],"domain_scores_gemma":[0.998956,0.0002628542,0.0004152737,0.00012052409,0.00019068424,0.00005465871],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007511135,0.00010003193,0.00029029846,0.000065827706,0.000027854216,0.00001941375,0.000098109,0.00017192814,0.000019698191],"category_scores_gemma":[0.000527006,0.000068644746,0.00017518697,0.00008205068,0.00008841321,0.000009817207,0.00003368304,0.00008502881,4.3913593e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002624571,0.001064093,0.99458754,0.0000062797594,0.00015691997,0.00007738502,0.000008595756,0.00007390849,0.0028579028,0.00009800402,0.00027188956,0.0005350132],"study_design_scores_gemma":[0.0019195752,0.00064486125,0.9888041,0.000016000444,0.000015738317,0.0001272974,0.00006449255,0.000056039094,0.007458255,0.000057371435,0.0007833916,0.000052852152],"about_ca_topic_score_codex":0.000015871308,"about_ca_topic_score_gemma":0.00002341037,"teacher_disagreement_score":0.005783426,"about_ca_system_score_codex":0.00006285859,"about_ca_system_score_gemma":0.00017266652,"threshold_uncertainty_score":0.27992517},"labels":[],"label_agreement":null},{"id":"W4415356641","doi":"10.1080/09546634.2025.2572645","title":"Treating onychomycosis in diabetic patients: risk, therapy, and topical opportunity","year":2025,"lang":"en","type":"review","venue":"Journal of Dermatological Treatment","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mediprobe Research (Canada); University of Toronto","funders":"","keywords":"Comorbidity; Diabetes mellitus; Population; MEDLINE; Disease management; Disease","score_opus":0.08496539880020217,"score_gpt":0.3667495301076229,"score_spread":0.28178413130742075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415356641","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.04310219,0.95518315,0.0000010452044,0.00009867106,0.0000858083,0.00084440503,0.000097437725,0.000010331909,0.0005769757],"genre_scores_gemma":[0.007921363,0.9914805,0.00023257932,0.000074197145,0.00004404359,0.000064468346,0.00006084561,0.000012732433,0.00010923863],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977447,0.0004022017,0.0010821746,0.00026674196,0.00024223313,0.00026198657],"domain_scores_gemma":[0.9979511,0.00064258213,0.00070888,0.0002124406,0.0000815648,0.00040347068],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000875819,0.00044578343,0.0027214647,0.00030266153,0.000064777225,0.000028518798,0.00008738736,0.00028412885,0.00008195611],"category_scores_gemma":[0.0003438093,0.00022608416,0.00084393786,0.0002127219,0.00005596001,0.00005153403,0.000040984618,0.0003590823,0.0000033323486],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008247822,0.0028430184,0.20835681,0.0012960418,0.0007123679,0.0009899328,0.000012975843,4.058979e-8,4.235282e-9,0.000014825109,0.000053779822,0.78563774],"study_design_scores_gemma":[0.023802705,0.008277707,0.2704396,0.03873623,0.014394838,0.0015330943,0.000063082,0.0000044841536,0.000002592177,0.00033716697,0.64171976,0.0006887726],"about_ca_topic_score_codex":0.00001614959,"about_ca_topic_score_gemma":0.0000021644162,"teacher_disagreement_score":0.78494895,"about_ca_system_score_codex":0.00044625057,"about_ca_system_score_gemma":0.00037946066,"threshold_uncertainty_score":0.92194444},"labels":[],"label_agreement":null},{"id":"W4415691157","doi":"10.1080/09546634.2025.2572655","title":"A CollaboraTive Initiative of worldwide Vitiligo Experts and patients to define vitiligo activity (ACTIVE): study protocol","year":2025,"lang":"en","type":"article","venue":"Journal of Dermatological Treatment","topic":"melanin and skin pigmentation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"Vlaamse regering; Universiteit Gent; Pfizer","keywords":"Vitiligo; Protocol (science); Comparability; Clinical trial; Consistency (knowledge bases); Disease; Quality of life (healthcare)","score_opus":0.013716785651510995,"score_gpt":0.3356993190594204,"score_spread":0.3219825334079094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415691157","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9867987,0.00003421175,0.00020634469,0.00019647296,0.000046379246,0.012141106,0.000021409422,0.0000022637505,0.0005531208],"genre_scores_gemma":[0.9951879,0.000016462485,0.0005410498,0.00014250571,0.000015113117,0.004059805,0.0000053328827,0.000004474311,0.000027349992],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99896944,0.0002427444,0.00035009993,0.00017713448,0.00014525084,0.00011535471],"domain_scores_gemma":[0.9992086,0.00006526433,0.00027370563,0.000105390434,0.00026510507,0.00008187643],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007322445,0.00015355847,0.00034543782,0.00008986073,0.000053097545,0.00001387667,0.000069385176,0.00006707198,0.000008713923],"category_scores_gemma":[0.000121332065,0.00010066527,0.00006782394,0.00014837012,0.00004512404,0.000010115879,0.0000597481,0.00004324317,4.4314615e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014619248,0.016328327,0.788256,0.00008972041,0.0016815559,0.00019131949,0.003361892,0.000032847176,0.11886644,0.00009555937,0.002936117,0.053540967],"study_design_scores_gemma":[0.0077722166,0.0080835875,0.33383584,0.00006820011,0.00008704207,0.000023714203,0.0026219136,0.000004958126,0.6454531,0.000106578686,0.0017998398,0.00014302073],"about_ca_topic_score_codex":0.0000043470036,"about_ca_topic_score_gemma":0.000020164904,"teacher_disagreement_score":0.52658665,"about_ca_system_score_codex":0.00006185413,"about_ca_system_score_gemma":0.00009370695,"threshold_uncertainty_score":0.41050103},"labels":[],"label_agreement":null},{"id":"W4415851239","doi":"10.1080/09546634.2025.2580374","title":"Comparative efficacy of omalizumab, dupilumab, and remibrutinib in chronic spontaneous urticaria: a network meta-analysis of randomized control trials","year":2025,"lang":"en","type":"review","venue":"Journal of Dermatological Treatment","topic":"Urticaria and Related Conditions","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Western University; McMaster University","funders":"","keywords":"Omalizumab; Randomized controlled trial; Dupilumab; MEDLINE; Clinical trial; Minimal clinically important difference","score_opus":0.16996052305305887,"score_gpt":0.42322423949391713,"score_spread":0.25326371644085827,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415851239","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0008248959,0.99524724,0.00013039519,0.0003219545,0.00008327786,0.0028368458,0.00014741269,0.000007837343,0.0004001092],"genre_scores_gemma":[0.044966828,0.95427245,0.00040499924,0.000023397695,0.00005513253,0.00012822666,0.0000639924,0.000010985647,0.000074013784],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.98887986,0.0044255923,0.005668386,0.00031864294,0.00040274186,0.00030477997],"domain_scores_gemma":[0.97637326,0.018776871,0.0040424024,0.00035140035,0.0002608984,0.00019517285],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":["metaepi_broad"],"category_scores_codex":[0.0016632983,0.00056116394,0.03684432,0.0009330774,0.000043711672,0.000015313295,0.00015460468,0.0005910147,0.0003317579],"category_scores_gemma":[0.0015317495,0.0002572302,0.011623013,0.0010983025,0.00036989723,0.000029108405,0.000034407876,0.0005234863,0.0000016851429],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017119968,0.0012268223,0.000014252056,0.00084353803,0.970119,0.0037901679,0.00010477551,0.00048068332,0.000001437267,0.0010224781,0.00006831518,0.0052085626],"study_design_scores_gemma":[0.10821538,0.00080320454,0.000043099397,0.0022902698,0.8820223,0.0027434826,0.000015519856,0.00016923001,0.000003856976,0.00013646124,0.0034141543,0.00014299592],"about_ca_topic_score_codex":0.000013015204,"about_ca_topic_score_gemma":0.000008964172,"teacher_disagreement_score":0.09109541,"about_ca_system_score_codex":0.0003880164,"about_ca_system_score_gemma":0.0010486367,"threshold_uncertainty_score":0.999988},"labels":[],"label_agreement":null},{"id":"W4417274052","doi":"10.1080/09546634.2025.2588072","title":"What is the optimal sequential therapy after secondary IL-17A inhibitor failure in psoriasis: switching to an IL-23 inhibitor or to another IL-17A inhibitor?","year":2025,"lang":"en","type":"article","venue":"Journal of Dermatological Treatment","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health","funders":"National Key Research and Development Program of China; National Natural Science Foundation of China","keywords":"Drug; Enzyme inhibitor; Chemotherapy; Clinical trial","score_opus":0.023824284592163847,"score_gpt":0.2812734661010952,"score_spread":0.25744918150893137,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417274052","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97693026,0.0054877503,0.00011071167,0.012992337,0.003069784,0.001106758,0.00016575576,0.00005771021,0.00007890478],"genre_scores_gemma":[0.99083036,0.0012610747,0.0011413995,0.004886348,0.00046757635,0.00029111927,0.00003202592,0.000046367928,0.0010437444],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99609405,0.0009184804,0.0012811655,0.00068177725,0.00020345463,0.0008210632],"domain_scores_gemma":[0.99835575,0.00037481188,0.00037235397,0.0005488151,0.00017337585,0.00017490114],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00046097487,0.0007361234,0.0011845859,0.00053078536,0.00033955436,0.00026691213,0.00052842236,0.00065636716,0.0007151312],"category_scores_gemma":[0.000055419405,0.00039225852,0.0005772563,0.0005827153,0.0001173689,0.00067043485,0.00018262936,0.00055855396,0.00025040662],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04304145,0.010739449,0.032241564,0.00010637324,0.0078080758,0.0056138667,0.03477109,0.00025821174,0.2830047,0.000240317,0.036749557,0.54542536],"study_design_scores_gemma":[0.02332109,0.008256729,0.022798223,0.0010356371,0.00081287883,0.0022484437,0.010446192,0.000008904783,0.6142631,0.00036037274,0.31515175,0.0012966571],"about_ca_topic_score_codex":0.000028620867,"about_ca_topic_score_gemma":0.00021033894,"teacher_disagreement_score":0.54412866,"about_ca_system_score_codex":0.00045101534,"about_ca_system_score_gemma":0.00035315464,"threshold_uncertainty_score":0.99985296},"labels":[],"label_agreement":null},{"id":"W4417358255","doi":"10.1080/09546634.2025.2598183","title":"Tildrakizumab in real-world Chinese psoriasis: efficacy-safety profiles from a 28-week retrospective cohort with geriatric, late-onset and metabolic syndrome stratification","year":2025,"lang":"en","type":"article","venue":"Journal of Dermatological Treatment","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health","funders":"National Key Research and Development Program of China; National Natural Science Foundation of China","keywords":"Psoriasis; Retrospective cohort study; Metabolic syndrome; Cohort; Cohort study; Plaque psoriasis","score_opus":0.01267823375081535,"score_gpt":0.2569125784295141,"score_spread":0.24423434467869876,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417358255","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9910837,0.006568621,0.000027208744,0.0005327218,0.00028680288,0.0006787079,0.00015511838,0.0000395094,0.0006276305],"genre_scores_gemma":[0.9948151,0.0039310995,0.00054683373,0.000030174744,0.000022670132,0.000076696786,0.0001541685,0.000012384283,0.00041086267],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979004,0.0004809409,0.0008039452,0.00040499415,0.000094246265,0.00031545688],"domain_scores_gemma":[0.99863535,0.0004500992,0.00048264902,0.00026946093,0.00010615644,0.000056288143],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020409032,0.00038798316,0.0012207207,0.00037756393,0.00016475492,0.00003892829,0.00017019629,0.00025582706,0.00011527296],"category_scores_gemma":[0.00006675869,0.00021972672,0.00017907015,0.00053952227,0.00014712352,0.00014859668,0.000037229187,0.00024139295,0.000021107697],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026387423,0.0016774829,0.98561364,0.000008860488,0.002372533,0.0005741399,0.0002395874,0.0000129148075,0.0006164245,0.00035119985,0.0000742197,0.005820261],"study_design_scores_gemma":[0.007690534,0.0007478402,0.9851891,0.00008207974,0.00090271886,0.00065140566,0.00009049972,0.0000041462067,0.003384883,0.00079682766,0.00026808959,0.00019188953],"about_ca_topic_score_codex":0.00023159033,"about_ca_topic_score_gemma":0.00027034996,"teacher_disagreement_score":0.0056283716,"about_ca_system_score_codex":0.00027831792,"about_ca_system_score_gemma":0.00015947109,"threshold_uncertainty_score":0.8960195},"labels":[],"label_agreement":null},{"id":"W7117452601","doi":"10.1080/09546634.2025.2592448","title":"A novel nomogram based on clinical features and laboratory parameters to predict biologic-refractory psoriasis patients","year":2025,"lang":"en","type":"article","venue":"Journal of Dermatological Treatment","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health","funders":"National Key Research and Development Program of China; National Natural Science Foundation of China","keywords":"Nomogram; Psoriasis; Predictive value of tests; Clinical trial","score_opus":0.030167742732322405,"score_gpt":0.3003088606808256,"score_spread":0.27014111794850315,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7117452601","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949087,0.0015144907,0.00021025118,0.0009708609,0.0014158988,0.000428859,0.0001935263,0.00004059521,0.00031680753],"genre_scores_gemma":[0.9960751,0.00032796015,0.0019027889,0.0014420232,0.00003489687,0.00004126562,0.000044544013,0.000009561637,0.00012187368],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979551,0.0005032888,0.0007632067,0.00036113273,0.00007864804,0.00033866597],"domain_scores_gemma":[0.9979794,0.0011276947,0.00035181886,0.0002574191,0.00016328767,0.000120383054],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002734472,0.00034625694,0.0008244671,0.0002871661,0.00015579321,0.000028488897,0.00020462806,0.0004797978,0.00003483012],"category_scores_gemma":[0.0004370108,0.00019976402,0.00034910633,0.00023239732,0.00017708393,0.000056665147,0.000047984948,0.00025980093,0.00003411559],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004266023,0.00874423,0.85272217,0.000017489818,0.0019669342,0.00013601438,0.00007367607,0.000048565566,0.0017489846,0.00016711962,0.007544634,0.122564144],"study_design_scores_gemma":[0.014317838,0.010775765,0.93913215,0.0001381912,0.0007241258,0.00008386137,0.00008028774,0.00000431903,0.0075186254,0.00007814367,0.026856748,0.00028996225],"about_ca_topic_score_codex":0.0000069550406,"about_ca_topic_score_gemma":0.000004059661,"teacher_disagreement_score":0.12227418,"about_ca_system_score_codex":0.00014167462,"about_ca_system_score_gemma":0.000125319,"threshold_uncertainty_score":0.81461406},"labels":[],"label_agreement":null}]}